Firmenich
acquires Campus to expand its natural & clean label
capabilities for protein
solutions- 7 August 2018 -Firmenich acquires
Campus, an innovator in the application of natural
functional ingredients for protein applications,
specializing in clean label, meat, dairy, sauces and
plant-based food. This acquisition broadens Firmenichs
capabilities in naturals and protein solutions, cutting
across animal and vegan food products. Campus was founded in
2005 in Parma, at the heart of Italys Food
Valley, by Giampaolo Cagnin with a focus on meat. Over
the years, the Company has developed deep expertise and
applications knowledge in using natural products, such as
fibers, to create customized functional solutions for a
broad range of protein applications. Campus operates
research and production facilities in Italy, and is
expanding its footprint globally with a state-of-the-art
production plant in Monterrey, Mexico due to start
production later this year.

I am delighted to be welcoming
Campus into the Firmenich family, as we share common values,
a commitment to world-class research and to leading
innovation in natural solutions, said Patrick
Firmenich, Chairman of the Board, Firmenich. Giampaolo
Cagnin and Federico Fulgoni, Campuss CEO, have built
an impressive organization that we look forward to taking to
the next level to offer our customers a complete natural
taste experience. With Firmenichs
excellence in research and global market reach, I am excited
about the many opportunities ahead for Campus,
remarked Federico Fulgoni, CEO of Campus. By combining
our capabilities we will accelerate our longstanding goal of
offering the most comprehensive range of clean label
solutions for protein applications, cutting across animal
and plant-based products. Campus is a company
that has been built on innovation and has made its mark in
protein solutions, said Gilbert Ghostine, CEO,
Firmenich. We look forward to working together to
expand its reach globally and leverage its capabilities into
new categories such as dairy and plant-based solutions to
make our customers win today and tomorrow.

Reopening
of Givaudans tender offer for the remaining shares of
Naturex on 8 August 2018- 7 August 2018
-Following
the closure of the tender offer period initiated by Givaudan
for the remaining outstanding shares of Naturex, Givaudan
now holds 9,358,019 of Naturex shares, representing 97.24%
of the capital, based on the total number of shares as of 31
July 2018. This includes the successful acquisition of 40.5%
of the shares of Naturex prior to the launch of the tender
offer, which was completed on 4 June 2018. The tender offer
will now re-open from 8 August 2018 until 3 September 2018
inclusive, under the same terms. In accordance with the
initial tender offer, Givaudan confirms its intention to
implement a squeeze-out procedure along with the delisting
of Naturex shares from the Euronext Paris stock exchange,
following the closure of this offer period.

Sensient
Flavors & Fragrances Group 1st Half 2018
Sales-
Milwaukee, July 20, 2018 - Milwaukee, July 20, 2018 - The
Flavors & Fragrances Group reported revenue of $198.7
million and $185.6 million (+7.1%) in the second quarters of
2018 and 2017, respectively. Operating income was $24.0
million in the quarter compared to $28.5 million in last
years quarter (-15.8%). In the first six months of 2018, the Flavors
& Fragrances Group reported revenue of $387.0 million
compared to $372.4 million in the first six months of 2017
(+3.9%). Segment operating income was $49.3 million in the
first six months of 2018 and $57.3 million in the first six
months of 2017 (-13.9%).

Givaudan
2018 Half year results- 19 July 2018 - Givaudan Group sales
for the first six months of the year were CHF 2,674 million,
an increase of 5.6% on a like-for-like basis and 7.7% in
Swiss francs.Fragrance Division sales were CHF 1,223
million, an increase of 6.5% on a like-for-like basis and
7.5% in Swiss francs.Flavour Division sales were CHF 1,451
million, an increase of 4.9% on a like-for-like basis and
7.8% in Swiss francs.The gross profit increased by 4.4% from CHF
1,132 million in 2017 to CHF 1,182 million in 2018. Despite
continued productivity gains and cost discipline, the gross
margin declined to 44.2% in 2018 compared to 45.6% in 2017,
as a result of a lower gross margin in the Fragrance
Division.Net income for the first six months of 2018
was CHF 371 million compared to CHF 384 million in 2017, a
decrease of 3.4%, resulting in a net profit margin of 13.9%
versus 15.5% in 2017. Basic earnings per share were CHF
40.26 versus CHF 41.70 for the same period in
2017.

Evolva
announces Oliver Walker to succeed Simon Waddington as
CEO -
10 July 2018  Evolva (SIX: EVE)
announces today that as part of entering the next phase of
its evolution, the current Evolva CEO Simon Waddington steps
down as CEO with immediate effect. Until he will leave the
company towards the end of 2018, he will support the new CEO
in completing work on Evolvas technology base. This
will include the building of a framework for an innovation
pipeline that will deliver commercially attractive new
products.Our current CFO, Oliver Walker, who has
co-led the companys strategic development, will be
Evolvas new CEO. He will retain his financial
responsibilities with the current VP Finance Alessandro Del
Fabro leading the financial operations. Scott Fabro,
Evolvas Chief Commercial Officer, will additionally
assume the role of Chief Operating Officer as he will be
taking responsibility also for the supply chain. There are
no near-term plans to expand the executive management team
as Evolvas R&D activities in Reinach will be led
by Astrid Schäfer. She joined Evolva in 2010 and held
several critical research roles. Simon, Oliver and Scott have led the
planning and execution of the Company's corporate
restructuring and transformation from July 2017. The
important achievements have been raising CHF 86M in equity
in November 2017, significantly reducing the cash burn rate,
centralizing most R&D activities in the Swiss
headquarters and building a strong commercial organization.
In addition, during the past 12 months Evolva has filed for
registration of its breakthrough, next-generation pest
control product nootkatone and restructured the
Cargill-stevia commercial agreement to maximize shareholder
value with reduced financial commitments.As the major parts of restructuring are
completed, Evolva now enters the next phase of its
development with a strong focus on commercial and
operational activities. This will also include expanding the
current product range with ready-to-go-to-market
products and exploiting Evolvas ability to rapidly go
from product concept to commercial reality. The new CEO will
be physically located at Evolvas headquarters in
Reinach, Switzerland, with the COO being located in the USA,
the main market for Evolvas innovative
products.Gerard Hoetmer, Chairman of Evolvas
Board of Directors, said On behalf of the whole Board,
I would like to thank Simon for all his efforts in building
Evolva during the last seven years and especially to carry
out the transformation during the last twelve months. We are
confident that under Olivers leadership Evolva will
further accelerate its activities to build the business and
reach its true potential.

Givaudan
completes the acquisition of Expressions
Parfumées -
Geneva, 4 June 2018
- Givaudan, the global leader in
flavours and fragrances, today announced it has completed
the acquisition of Expressions Parfumées, a French
fragrance creation house, from its current shareholders,
Orfite and Expressions Parfumées management.
Founded in Grasse in 1982, Expressions Parfumées is a
pioneer of natural fragrance compounds and offers its
NATCO® range of perfumes designed to adapt to any
production labelled organic. Givaudan had
entered in exclusive negotiations to acquire Expressions
Parfumées in December 2017.

Takasago
Full Year 2017-2018 Sales - May
15, 2018 - For the fiscal year ending March 31, 2018
Consolidated net sales rose 3.5% year on year, to
¥141,592 million. Net sales in the flavors business
rose 1.5% year on year, to ¥83,312 million, due to the
strong performance of the German subsidiary. In the
fragrances business, net sales rose 6.3% year on year, to
¥38,183 million, due mainly to the solid performance of
the French subsidiary. In the aroma ingredients business,
net sales rose 8.4% year on year, to ¥11,409 million
due to the steady performance of menthol, the mainstay
product of this business segment. In the fine chemical
business, net sales rose 6.7% year on year, to ¥7,246
million, due to growth in the sales of pharmaceutical
intermediates. In the other business, the real estate
business, net sales rose 1.1%, to ¥1,441 million.
Operating income during this period fell 11.2% year on year,
to ¥6,358 million. Ordinary income fell 13.2% year on
year, to ¥6,720 million.

Symrise
1st Qtr 2018 Sales- May 8, 2018 - Group sales up by 1.5
% to € 776.9 million, including portfolio and exchange rate
effects and EBITDA margin with 20.1 % in target corridor.
Symrise AG remains on track for strong growth in the fiscal
year 2018 and achieved a very healthy 7.5 % organic increase
in sales in the first quarter. All segments benefited from
good demand. Taking into account portfolio and exchange rate
effects, sales in the first quarter were up 1.5 % to € 776.9
million (Q1 2017: € 765.2 million). Earnings before
interest, taxes, depreciation and amortization (EBITDA)
amounted to € 155.8 million. Due to negative currency
effects and higher raw material costs, it came in lower than
in the prior-year period (Q1 2017: € 165.5 million).
Scent & Care posted a 6.9 % organic
sales increase in the first quarter. Considering the
negative currency effects and the portfolio effect from the
Citratus acquisition, sales in reporting currency amounted
to € 331.8 million, and thus were slightly lower than
year-on-year.The Aroma Molecules division delivered the
strongest growth, with organic double-digit percentage
increases, in particular in applications for fragrance
ingredients.The Cosmetic Ingredients division achieved
strong organic growth in the high single-digit percentage
range, showing particularly expansive developments in the
Asia/Pacific and Latin America regions.The Fragrance division reported a moderate
organic increase in sales, especially driven by the Beauty
Care and Home Care business units. Beauty Care, which
develops and markets body and facial care applications,
realized strong organic growth especially in the
Asia/Pacific and Latin America regions. In the Home Care
business unit, healthy increases were seen in the
Asia/Pacific, EAME and Latin America regions, mainly through
new business with regional customers. The Fine Fragrances
business unit achieved a double-digit growth rate in Latin
America as a result of higher demand from regional and local
customers.The EBITDA for the Scent & Care segment
in the first quarter amounted to € 64.8 million (Q1 2017: €
71.9 million). The year-on-year decrease reflects negative
currency effects, higher prices for raw materials and the
one-off gain from the sale of the Pinova industrial
activities. The EBITDA margin was 19.5 % (Q1 2017: 21.6
%).
Sales in the Flavor segment, which encompasses the business
activities with flavors for foods and beverages, grew
organically in the first quarter at a very dynamic rate of
11.0 %. All business units and regions showed significant
increases in sales. Taking into account exchange rate
effects and the Cobell acquisition, sales in this segment
were up 7.8 % in reporting currency in the first quarter to
€ 291.2 million (Q1 2017: € 270.2 million).
In the Flavor segment, EBITDA increased to € 61.0 million.
This result was € 4.1 million higher than in the same period
a year earlier (Q1 2017: € 56.9 million) despite unfavorable
exchange rates, and represents an increase of 7.2 %. The
EBITDA margin, at 20.9 %, was down slightly (Q1 2017: 21.1
%), mainly as a result of the Cobell acquisition.

IFF
1st Qtr 2018 Sales- May 8, 2018 - Reported net sales
for the first quarter totaled $931 million, an increase of
12% from $828 million in 2017. Excluding the impact of
foreign exchange, currency neutral sales increased 7% over
the prior year.

Reported operating profit for the first
quarter was $175 million versus $130 million reported in
2017, an increase of 34%. Excluding the impact of foreign
exchange and those items that affect comparability, currency
neutral adjusted operating profit grew 12%, principally
driven by volume growth, the benefits associated with cost
and productivity initiatives and favorable sales
mix.

Reported earnings per share (EPS) for the
first quarter was $1.63 per diluted share versus $1.45 per
diluted share reported in 2017. Excluding the impact of
foreign exchange and those items that affect comparability,
currency neutral adjusted EPS improved 12%.

Flavors Business Unit - On a
reported basis, sales increased 11%, or $42.9 million, to
$449.0 million. Currency neutral sales grew 6% driven by
growth in all categories and nearly all regions. EAME
increased 24% on a reported basis and 11% on a currency
neutral basis, led by strong double-digit growth in Africa
and the Middle East as well as mid-single digit growth in
Europe. Growth was achieved across all categories, led by
strong performances in Dairy, Savory, and Beverage. North
America improved 10% driven by double-digit growth at
Tastepoint? and strong new wins in Beverage and Dairy. Latin
America decreased 2% on a reported and currency neutral
basis. Mid-single digit growth in South Cone was more than
offset by softness in Mexico and Colombia  both of
which grew strong double-digits in the year-ago period. On a
category basis, strong double-digit growth was achieved in
Savory as well as low-single digit growth in Dairy. Greater
Asia increased 6% on a reported basis and 2% on a currency
neutral basis, as double-digit growth in India and China was
muted by softness in Indonesia and the ASEAN region. On a
category basis, growth was strongest in Sweet, Savory and
Dairy.

Fragrances Business Unit - On a
reported basis, sales increased 14%, or $59.8 million, to
$481.9 million. Currency neutral sales improved 8%, with
broad-based growth from all categories and regions. Fine
Fragrances increased 12% on a reported basis and 4% on a
currency neutral basis led by strong double-digit growth in
LATAM and North America. Consumer Fragrances grew 11% on a
reported basis and 6% on a currency neutral basis with
growth achieved in all categories. Performance was led by
high-single digit increases in Home Care, Toiletries, and
Hair Care. On a geographic basis, growth was broad-based,
with all regions contributing positively to the results.
Fragrance Ingredients grew 26% on a reported basis and 18%
on a currency neutral basis, with growth in all regions as
well as very strong double-digit growth in Cosmetic Active
Ingredients. Fragrances segment profit increased 20% on a
reported basis and 12% on a currency neutral basis driven
primarily by volume growth and the benefits from cost and
productivity initiatives.

IFF
to Acquire Frutarom- May 7, 2018 - International Flavors
& Fragrances Inc. and Frutarom today announced that they
have entered into a definitive agreement under which IFF
will acquire Frutarom in a cash and stock transaction valued
at approximately $7.1 billion, including the assumption of
Frutaroms net debt. Under the terms of the agreement,
which has been unanimously approved by the Boards of
Directors of both companies, Frutaroms shareholders
will receive for each Frutarom share $71.19 in cash and
0.249 of a share of IFF common stock, which, based on the
10-day volume weighted average price (VWAP) for IFFs
common stock for the period ending May 4, 2018, represents a
total value of $106.25 per share.

Evolva
Provides 2017 Financial Results and Business
Highlights - May 2 & March
20, 2018 - Evolva posted its financial results for the
period from 1 January to 31 December 2017, and provided
business highlights that illustrate how the Company is
executing on its strategic transformation plan which was put
in place last August. Elements of this transformation have
included accelerating growth of our commercial products,
building stronger R&D operations, successfully
streamlining our operations and fortifying our cash balance.
These elements have provided Evolva with a strong base to
grow our product revenues while strengthening our
world-class research and development capabilities to bring
important products to market quickly.

Key business highlights - EverSweetTM
- In a joint press release, Cargill and Evolva announced the
official start of the commercial production of
EverSweet to fill customer orders. Additionally,
Cargill and Evolva reached a new agreement for the
EverSweet sweetener which replaces the existing
agreements, and adds certain additional high intensity
sweeteners. Under this new agreement, Evolva will receive a
royalty percentage on the sales of EverSweet, which
will accrue to Evolva as soon as EverSweet starts
generating revenues. Evolva will benefit from a significant
reduction of operational and capital expenses while
maintaining long term value.Nootkatone pest control products - Evolva has filed
for US EPA registration for the active ingredient
nootkatone, a process that is expected to be completed by
the end of 2018. In parallel, Evolva is actively engaged in
discussions with leading pest control product companies to
supply nootkatone for next-generation tick and mosquito
products.Resveratrol products - Following on the heels of the
launch of our
Veri-teTM
brand, revenue growth is accelerating.

Financial highlights:
*Product sales up by 82% in 2017 to reach CHF 2.0
million
* Overall revenues were CHF 6.8 million (2016: CHF 9.6m),
the decline being related to the reduced activities on
contract R&D work, which is in line with our announced
strategy
*Cash position of CHF 97.2 million on 31 December 2017 (31
December 2016: CHF 47.5m)

Senomyx
Reports First Quarter 2018 Financial Results- 26 April 2018 - Total revenues of $3.1
million for the first quarter ended March 31, 2018 exceeded
previously provided financial guidance of $3.0 million.
Commercial revenues of $1.4 million met guidance for the
first quarter of 2018, and represented a decrease from $2.6
million for the first quarter of 2017. Development revenues
for the first quarter of 2018 decreased to $1.7 million from
$1.8 million in the first quarter of the prior year. The
first quarter of 2018 resulted in a net loss of $3.8
million, or $(0.08) per share, which represented an
improvement over guidance of a net loss of $4.2 million, or
$(0.09) per share, and a decline compared to the first
quarter of 2017, which resulted in a net loss of $3.4
million, or $(0.07) per share. At March 31, 2018, Senomyx
had no debt and $18.1 million in cash, which was an increase
of $2.2 million from the prior quarter. The increase in cash
resulted primarily from the collection of accounts
receivable for royalty payments earned in 2017.

Frutarom
- A Potential Target for Acquisition- 12 April 2018 - In recent days it has been
reported that both International Flavors & Fragrances
(IFF) or Symrise may be interested in the acquisition of
Frutarom. Such an acquisition would be the largest since
Givaudan's purchase of Quest from ICI in early
2007.

Givaudan
1st Qtr 2018 Sales- 10 April 2018 - In the first three
months of 2018 Givaudan recorded sales of CHF 1,308 million,
an increase of 5.0% on a like-for-like basis, and 5.4% in
Swiss francs compared to the previous year. The Fragrance
Division recorded sales of CHF 604 million, a growth of 5.7%
on a like-for-like basis and an increase of 4.9% in Swiss
francs. The Flavour Division reported sales of CHF 704
million, an increase of 4.5% on a like-for-like basis and
5.8% in Swiss francs. Including Vika B.V., acquired in
September 2017, the growth was 7.0% in local currency.
Interestingly, earnings were not reported in this
release.

Robertet
Full Year 2017 Sales
- April 25, 2018 - Consolidated sales
for 2017 amounted to 504 million euros, an increase of 7, 7%
compared to 2016, 9.3% at constant exchange rate. This
revenue, 85% of which is generated outside France, is
Europe, and in Asia, according to the Group's objectives. By
division, Commodities have increased by 10.6%, Perfumery by
12.4% and Aromas by 1.4%. Consolidated net profit,
unaudited, is in the order of 48.5 million euros against
41.8 million the previous year, including a decrease in
deferred taxes of 2 million euros.

Frutarom
Full Year 2017 Sales- March 20, 2018 - In 2017 Sales grew
by 18.8% to a record US$ 1,362.4 million, constant currency
pro forma growth of 6.4%In 2017 Frutarom Carried Out 12 Strategic
Acquisitions, and 2 additional ones were already performed
in 2018 in Exchange for a Total of US$ 390
MillionSales from Core Activities grew by 19.1% to
a record US$ 1,271.4 million, constant currency pro forma
growth of 7.5%Sales from Flavors activity grew by 21.1% to
a record US$ 1,025.4 million, constant currency pro forma
growth of 7.2%Sales from Natural Specialty Fine
Ingredients grew by 14.2% to a record US$ 260.1 million,
constant currency pro forma growth of 11.8%Record level profits from operating
activities for 2017: ° Gross profit grew by 20.0% to US$
525.1 million;° EBITDA grew by 33.9% to US$ 259.6
million; ° Adjusted for nonrecurring expenses3
the EBITDA grew by 23.1% to a record 267.5
million;° Net income grew by 36.5% to US$ 151.6
million;A record cash flow from operations grew by
50.5% to US$ 187.5 millionEarnings per share grew by 36.0% to a record
US$ 2.52 million

Frutarom Expects 2018 to be Yet Another
Record Year, as it Continues to Improve its Profitability,
also through Projects for Combining Plants and Resource
Optimization, and the Successful Completion of the Enzymotec
Acquisition. Frutarom is Progressing towards Achieving its
Sales Target of US$ 2.25 B, and an EBITDA Margin from Core
Activity of 23% in 2020

Symrise
Full Year 2017 Sales- March 14, 2018 - Dynamic organic
growth in sales - Symrise increased its sales to €
2,996.3 million (2016: € 2,903.2 million) and benefited from
strong organic growth of 6.3 %. Taking portfolio effects
into account - in particular the sale of the industrial
activities of Pinova in December 2016 and the acquisitions
of Nutraceutix, Nutra Canada and Cobell - as well as
exchange rate effects, sales grew by 3.2 %.Strong demand especially in Latin America
and EAME - The largest sales growth was realized in
Latin America, where sales were up by a substantial 7.6 %.
Sales in North America showed a 4.1 % year-on-year decrease
due to the divestment of Pinova's industrial activities in
December 2016. The Asia/Pacific region achieved a modest
increase of 1.4 %. With a strong 7.4 % rise in sales, the
EAME region showed an even more dynamic development than in
the previous year. The share of Emerging Markets in the
Group's total sales was slightly higher, at 44 % (2016: 43
%). Symrise achieved an overall 7.6 % increase in sales at
local currency in those countries.High profitability maintained -
Despite unfavorable currency effects, higher costs for raw
materials and investments in expansion, Symrise was able to
increase its EBITDA to € 630.3 million (2016 normalized: €
625.2 million). At the same time, the Group was highly
profitable, with a very good EBITDA margin of 21.0 % (2016
normalized: 21.5 %). Net income of the Group increased 1.8 %
to € 270.3 million (2016 normalized: € 265.5 million).
Earnings per share improved to € 2.08 (2016 normalized: €
2.05). The Executive Board and Supervisory Board will
therefore propose an increase in the dividend from € 0.85 to
€ 0.88 per share at the Annual General Meeting on 16 May
2018.Scent & Care segment - The Scent
& Care segment achieved total sales of € 1,263.1 million
(2016: € 1,311.3 million). This year-on-year decrease of 3.7
% resulted from the sale of the industrial activities of
Pinova in December 2016 and a slower first half of the year.
Adjusted for portfolio and exchange rate effects, the
segment reported healthy organic growth of 3.9 % - buoyed in
particular by the strong fourth quarter, with an increase of
5.8 %. The strongest growth was posted by the Cosmetic
Ingredients division. Strong demand was seen especially in
the Asia/Pacific and EAME regions. EBITDA in the Scent &
Care segment amounted to € 248.1 million (2016 normalized: €
257.8 million). The 3.8 % decrease reflects higher raw
material costs, the sale of the Pinova industrial activities
and expenses for research and development. The EBITDA margin
remained stable at 19.6 % (2016 normalized: 19.7
%).Flavor segment - Sales in the Flavor
segment increased to € 1,101.9 million in the year under
review (2016: € 1,015.9 million). The segment achieved very
strong growth of 8.5 %. Excluding the portfolio effect from
the acquisition of Cobell and currency effects, organic
growth amounted to a very healthy 9.3 %. All regions and
application areas contributed to the positive sales
development. The segment continued the successful trend of
recent years, particularly in Europe, Africa and the Middle
East (EAME) as well as in North America. Growth was
particularly strong in the Sweets and Beverages application
areas as a result of new business with vanilla flavorings.
EBITDA in the Flavor segment amounted to € 242.9 million
(2016: € 233.8 million). This represents a 3.9 % increase as
compared with 2016. The EBITDA margin was a very
satisfactory 22.0 % (2016: 23.0 %).Nutrition segment - Nutrition posted
a substantial 9.6 % year-on-year plus in sales to € 631.3
million (2016: € 576.0 million). Adjusted for portfolio and
currency effects, organic sales growth in the segment
amounted to 6.5 %. The pet food application area was again
one of the strongest growth drivers, with at least
single-digit and sometimes even double-digit sales growth in
local currency in all four regions. The segment increased
its EBITDA by 4.3 % to € 139.4 million (2016: € 133.7
million). The EBITDA margin was at an outstanding 22.1 %
(2016: 23.2 %).

Takasago
3d Qtr 2017-2018 Sales - February
14, 2018 - For the first 3 Qtrs of the fiscal year,
consolidated net sales rose 0.5% year on year, to
¥106,057 million while Operating income during this
period fell 21.2% year on year, to ¥5,453 million.
Ordinary income fell 16.5% year on year, to ¥6,274
million. Net income attributable to the parent company fell
19.2% year on year, to ¥ 5,010 million.

Sensient
Flavors & Fragrances Group Full Year 2017
Results -
February 8, 2018 -The Flavors
& Fragrances Group reported revenue of $618.8 million
and $651.9 million for the full years of 2017 and 2016,
respectively for Traditional Flavors & Fragrances
(which excludes items such as dehydrated vegetables &
colors).

T.
Hasegawa1st Qtr 2017-2018 Sales
Results - February 8, 2018 - T.
Hasegawa's consolidated net sales were up 1.0% to ¥
11,655 million compared to ¥ 11,542 million in the
prior year Qtr. Net profit in the same perioid declined
34.9% to ¥ 1,079 million.

Reported net sales for the full year
totaled $3.4 billion, an increase of 9% from $3.1 billion in
2016. Excluding the impact of foreign exchange, currency
neutral sales also increased 9% over the prior year,
including approximately five percentage points related to
our recent acquisitions.

Reported operating profit for the full
year was $581 million versus $567 million reported in 2016,
an increase of 2%. Excluding the impact of foreign exchange
and those items that affect comparability, currency neutral
adjusted operating profit grew 5%, principally driven by
volume growth, the benefits associated with cost and
productivity initiatives and acquisitions.

Reported earnings per share (EPS) for
the full year was $3.72 per diluted share versus $5.05 per
diluted share reported in 2016. Excluding the impact of
foreign exchange and those items that affect comparability,
currency neutral adjusted EPS improved 9%, driven by
adjusted operating profit growth, a more favorable
year-over-year effective tax rate, and lower year-over-year
shares outstanding.

IFF Flavors Business Unit - On
a reported basis, sales increased 9%, or $135.6 million, to
$1.6 billion. Currency neutral sales grew 10% driven by
growth in all categories, and the contribution of sales
related to the acquisitions of David Michael and PowderPure.
Flavors segment profit increased 11% on a reported basis and
14% on a currency neutral basis, driven by volume growth,
the contribution of acquisitions and the benefits from
productivity initiatives. EAME increased 6% on a reported
basis and 8% on a currency neutral basis. North America
improved 23% reflecting additional sales related to
acquisitions as well as mid-single-digit growth on an
organic basis. Latin America increased 7% on a reported
basis and 6% on a currency neutral basis. Greater Asia
increased 1% on a reported and on a currency neutral
basis.IFF Fragrances Business Unit - On
a reported basis, sales increased 9%, or $146.7 million, to
$1.8 billion. Currency neutral sales also improved 9%. Fine
Fragrances increased 18% on a reported basis and 16% on a
currency neutral basis. Consumer Fragrances grew 7% on a
reported and currency neutral basis. Fragrance Ingredients
grew 8% on a reported and currency neutral basis. Fragrances
segment profit remained constant on a reported basis and
declined 1% on a currency neutral basis as volume growth,
the benefits from cost and productivity initiatives and the
contribution of acquisitions was offset by unfavorable price
to input costs, and higher research, selling and
administrative expenses, including higher incentive
compensation.

Avery
Gilbert's new study,
"Consumer perceptions of strain differences in Cannabis
aroma" has just been published (Feb 5, 2018) - It can be
downloaded here
- The study examined eleven
strains of cannabis purchased from licensed recreational
dispensaries in Colorado. Volunteers sniffed samples and
rated them on a ballot of odor descriptors. The results
revealed two basic aroma profiles: One is characterized as
earthy, woody, and herbal, and the other is described as
citrus, lemon, sweet, and pungent.

Sniff panelist rated the citrus,
lemon, sweet and pungent-smelling strains as more potent,
and were willing to spend more money to purchase them. Along
with my collaborator, analytical chemist Dr. Joseph A.
DiVerdi, we also found that smell-based perceptions of
cannabis potency are unrelated to the actual THC levels in
the samples.

This study is the first ever to
examine cannabis aroma with sensory evaluation techniques.
It is also the first public announcement from Headspace
Sensory LLC, the company I founded in 2016 to explore and
commercialize the strain-specific aroma profiles of
cannabis.

Givaudan
Full Year 2017 Results- 26
January 2018 - Givaudan Group full year sales were CHF 5,051
million, an increase of 4.9% on a like-for-like basis and
8.3% in Swiss francs when compared to 2016.

Net income of CHF 720 million, up 11.7%
year-on-year

Flavour Division sales were CHF 2,708
million, an increase of 5.3% on a like-for-like basis and
11.3% in Swiss francs.

Fragrance Division sales were CHF 2,343
million, an increase of 4.5% on a like-for-like basis and
5.1% in Swiss francs.

Givaudan
announces changes to the Executive
Committee- 08 January 2018 - Givaudan announced today
the appointment of Louie DAmico as President of the
Flavour Division and a member of the Executive Committee.
Louie DAmico will succeed Mauricio Graber, currently
President of the Flavour Division, who will leave the
Company to become Chief Executive Officer at Chr. Hansen, a
global bioscience company. Louie DAmico, currently
Head of Flavours Americas, will work closely with Mauricio
Graber to ensure a smooth transition over the coming months.
The changes to the Givaudan Executive Committee will be
effective 1 April 2018.

Firmenich
is acquiring Natural Flavors, Inc.- Geneva, Switzerland, December 21, 2017
 Natural Flavors, Inc., a privately-held manufacturer
of high-quality organic certified natural flavors.
Headquartered in Newark, NJ, U.S.A., Natural Flavors is
recognized as a pioneer in organic flavoring, including
having developed and commercialized the first organic
certified flavors in North America during the late 1990s.
Today, Natural Flavors offers an extensive range of organic
certified and natural flavor solutions to meet the needs of
food and beverage customers in high growth, in-demand
categories.

Huabao
Group F&F 6 Month 2017-2018
Sales - for the period ending
September 30, 2017 - November 21, 2017 - To date the F&F
sales for Huabao Group (which includes Flavors, Fragrances
and Aroma raw materials) were RMB 1,235.7 million (+11.7%)
as compred to RMB 1,106.7 million in the prior year. The
F&F segment sales are about 75% of Huabao's total sales,
the remainder being primarily tobacco products.

Frutarom
9 Month 2017 Sales- Haifa, Israel 2017 -
Frutaroms sales in the first nine months of 2017 rose
17.1% to a record US$ 1,004.9 million compared with US$
858.0 million in the same period last year, reflecting 6.0%
year-over-year growth in pro-forma terms on a constant
currency basis. Changes in the exchange rates of currencies
in which the Company operates as against the US dollar
boosted sales by 0.6%. Sales for Frutaroms core
activities (its Flavors activity and Specialty Fine
ingredients activity) rose 17.2% in the first nine months of
2017 to reach a record US$ 938.4 million compared with US$
800.6 million in the same period last year, reflecting 7.2%
year-over-year growth in pro-forma terms on a constant
currency basis. Changes in exchange rates boosted results by
0.3%. Sales from the Flavors activity rose 18.2% to reach
US$ 746.5 million in the first nine months of 2017 as
against US$ 631.7 million in the same period last year,
reflecting 6.2% year-over-year growth in pro-forma terms on
a constant currency basis. Currency effects boosted results
by 0.4%. Sales from Specialty Fine Ingredients activity rose
15.1% to US$ 200.2 million in the first nine months of 2017
compared with US$ 174.0 million in the same period last
year, reflecting 13.0% yearover-year growth in pro-forma
terms on a constant currency basis. Currency effects
negatively impacted sales by 0.5%. Sales from Trade and
Marketing (which does not constitute part of Frutaroms
core activities) rose 15.8% to reach US$ 66.5 million in the
first nine months of 2017 compared with US$ 57.4 million in
the same period last year, Contributing to the increase were
the added Trade and Marketing product sales of Piasa of
Mexico which was acquired in December 2016 and the currency
effects which boosted sales by 4.8%, In constant currency
and pro-forma terms, Trade and Marketing sales decreased by
8.9%.

Symrise
9 Month 2017 Sales- November 8, 2017 - Symrise achieved
strong organic sales growth of 6.5 % in the period from
January to September, including a 9.1 % increase in the
third quarter. Considering portfolio effects  namely
the sale of the industrial activities of Pinova in December
2016 and the Nutraceutix and Cobell acquisitions  as
well as exchange rate effects sales were up 3.9 % to €
2,278.4 million (9M 2016: € 2,192.3 million). Third quarter
sales were impacted by an unfavorable exchange rate
environment, especially the devaluation of the US dollar
against the euro. Symrise continued to operate highly
profitable in the first nine months of the year. Earnings
before interest, taxes, depreciation and amortization
(EBITDA) rose by 1.0 % to € 485.2 million (EBITDAN 9M 2016:
€ 480.3 million).

Scent & Care - Scent &
Care posted a 3.3 % organic sales increase in the first nine
months of the year. In the third quarter, organic growth
reached even 7.7 %. Taking into account the sale of Pinova
Inc., sales in the segment amounted to € 960.1 million; as
expected they were 3.7 % lower than in the first nine months
of 2016 (9M 2016: € 997.2 million). The strongest growth in
the segment was achieved by the Cosmetic Ingredients
division.

Aroma Molecules - Adjusted for the Pinova
portfolio effect, the Aroma Molecules division posted
moderate growth. Positive signals mainly came from the
national markets in the USA, Indonesia, Japan and China. The
integration of the Pinova fragrance business continued to
strengthen the division through a broader portfolio of
unique, natural ingredients.

The Fragrance division achieved moderate
growth in the first nine months of the year, with good
growth momentum in the third quarter.

The Flavor segment, which includes
taste applications, achieved organic growth of 10.0 % in the
first nine months. In the third quarter it reached even 12.7
% growth. Considering exchange rate effects and the Cobell
acquisition, the segment reported a sales plus of 8.6 % to €
842.6 million (9M 2016: € 775.9 million).

The Nutrition segment, which
includes the Diana division with applications for food, pet
food and baby food as well as probiotics, achieved an
organic growth of 7.8 % in the first nine months. In the
third quarter, organic sales growth amounted to 5.8 %.
Considering portfolio and exchange rate effects, the segment
had a 13.5 % increase in sales in the first nine months to €
475.7 million (9M 2016: € 419.2 million). The strongest
contributions came from the Pet Food business unit, which
posted high single-digit or even double-digit local currency
sales increases in all four regions.

IFF Fragrances Business Unit - On
a reported basis, sales increased 13%, or $53.0 million, to
$463.1 million while currency neutral sales improved 12%.
Overall growth was broad-based, with a balanced contribution
between organic and acquired business. Regionally, growth
was strongest in EAME and Latin America  increasing
double-digits  followed by mid-single-digit growth in
Greater Asia. Fine Fragrances improved 20% on a reported
basis and 18% on a currency neutral basis, inclusive of
additional sales related to the acquisition of Fragrance
Resources. Performance was driven by strong new wins in
EAME, Greater Asia and North America as well as improved
volume trends in Latin America. Consumer Fragrances grew 12%
on a reported basis and 11% on a currency neutral basis,
with a balanced contribution from organic business and
additional sales related to the acquisition of Fragrance
Resources. Within Consumer Fragrance, nearly all categories
achieved growth, led by double-digit growth in Home Care and
high-single-digit growth in Fabric Care. Fragrance
Ingredients grew 9% on a reported basis and 8% on a currency
neutral basis, with double-digit growth in Latin America and
EAME as well as double-digit growth in cosmetic active
ingredients. Fragrances segment profit increased 10% on a
reported basis and 6% on a currency neutral basis led by
volume growth, the contribution of acquisitions and the
benefits from productivity initiatives.

IFF Flavors Business Unit - On a
reported basis, sales increased 12%, or $42.9 million, to
$409.8 million while currency neutral sales grew 12%.
Overall growth was driven by additional sales related to the
acquisition of David Michael, as well as mid-single-digit
organic growth, where all categories improved
year-over-year. EAME increased 12% on both a reported and
currency neutral basis, inclusive of additional sales
related to the acquisition of David Michael, with the
strongest growth in Beverage, Savory and Dairy. On a
geographic basis, Western, Central and Southeast Europe as
well as Africa and the Middle East all reported strong
growth. North America grew 28% reflecting additional sales
related to the acquisition of David Michael and PowderPure
as well as high-single-digit growth on an organic basis.
Growth was strongest in Savory and Beverage, both driven by
new win performance. Latin America remained constant on a
reported basis and increased 1% on a currency neutral basis,
as growth in Colombia and Argentina more than offset
softness in Brazil. Greater Asia grew 2% on both a reported
and currency neutral basis, principally driven by growth in
India and Thailand with Savory being the strongest category.
Flavors segment profit grew 18% on a reported basis and 19%
on a currency neutral basis, driven by volume growth, the
contribution of acquisitions, and the benefits from
productivity initiatives

Sensient
Flavors & Fragrances Group 9 month 2017
Sales- Milwaukee, October 19, 2017
-The Flavors & Fragrances Group
reported revenue of $568.4 million and $608.7 million in the
first nine months of 2017 and 2016, respectively. Segment
operating income was $90.3 and $95.5 million in the first
nine months of 2017 and 2016, respectively. Foreign currency
translation reduced revenue and operating income by
approximately 1% each, in the first nine months of 2017. The
Flavors & Fragrances Group reported third quarter
revenue of $196.0 million, a decrease of approximately 2%
compared to $200.8 million reported in the comparable period
last year. Segment operating income was $33.0 million, an
increase of approximately 2% compared to $32.4 million
reported in the third quarter of 2016. The Groups
higher profit was a result of solid performances in the
Bionutrients, North America Savory, Europe Savory, Latin
America, North America Beverage and Natural Ingredients
businesses. Foreign currency translation increased revenue
by approximately 1% in the quarter and had a minimal impact
on operating income. It should be noted that the above
sales figures may include items not normally considered
Flavors & Fragrances - mainly natural ingredients such
as dehydrated vegetables, which historically have been about
18%+ of reported sales.

Notes
from Scent and Chemistry
- On Patchouli - October 28, 2017 - a
most comprehensive review on the essential oil of patchouli,
Pogostemon cablin (Blanco) Benth., by Teris A. van Beek and
Daniel Joulain, complementing chapter 7.6. on Patchouli Oil
(pp. 251), and updating especially on the situation after
the introduction of Clearwood (Firmenich), which is
detailed in section 5.2 (p. 35). van Beek and Joulain
clearly describe what Clearwood is, and what it is not
(a P. cablin extract). They also touch upon the dispute
whether perfectly pure ()-patchoulol was odorless or
not, as we detailed on S&C p. 253, and we are happy for
the confirmations. As van Beek and Joulain also mention, we
indeed (still) believe that (partial) anosimies do have
their share in some confusion about the odor of patchouli
oil. The article is open access, so free to download from
Wiley (DOI: 10.1002/ffj.3418), and totally worth a read:
http://onlinelibrary.wiley.com/doi/10.1002/ffj.3418/full

Halloween is
near - for those
interested in the analysis of the aroma of raw pumpkin
determined by our group - Look
here

Givaudan
2017 9 Month results- 10 October 2017 - In the first nine
months of 2017 Givaudan recorded sales of CHF 3,757 million,
an increase of 3.5% on a like-for-like1 basis and 6.8% in
Swiss francs compared to the previous year. Fragrance
Division sales were CHF 1,740 million, an increase of 2.2%
on a like-for-like basis and an increase of 2.5% in Swiss
Francs. Flavour Division sales were CHF 2,017 million, an
increase of 4.7% on a like-for-like basis and an increase of
10.9% in Swiss Francs. Total sales of Fragrance compounds
(Fine Fragrances and Consumer Products combined) increased
by 2.6% on a like-for-like basis. In Swiss francs, sales of
compounds increased by 3.0% to CHF 1,515 million from CHF
1,472 million in 2016.

The Flavour Division reported sales of
CHF 2,017 million, a growth of 4.7% on a like-for-like basis
and an increase of 10.9% in Swiss Francs. Givaudan
successfully closed the acquisition of Vika B.V. acquired in
September 2017. Including all acquisitions for the
comparable period the growth was 12.5% in local currency.
The sales performance was driven by new wins and strong
business expansion in North America, Europe, Middle East and
Africa. Asia Pacific grew whilst Latin America experienced a
decline compared to 2016, against strong comparables,
largely driven by challenging market conditions in Brazil.
From a segment perspective, Dairy, Savoury and Beverages all
contributed to the positive sales development.

Firmenich recorded 3.34 billion Swiss
francs (CHF) in net sales, an increase of +4.4% in CHF
versus the previous year. With all its Business Units
posting steady growth, the Group further consolidated its
number one position in Fine Fragrance and
Ingredients.

Taking its legacy of excellence forward,
the Company evolved its Board of Directors, starting with
the appointment of Patrick Firmenich as Chairman of the
Board and Barbara Kux as Vice-Chair. The Company also
welcomed two new board members: Richard Ridinger, CEO of
Lonza, and Pierre Bouchut, COO of Ahold Delhaize.

Firmenich reinforced its commitment to
Geneva, Switzerland this year, as it announced over CHF 160
million (m) investments. The Group inaugurated its new
cutting-edge Perfumery Plant in November, representing a CHF
60m and announced its intention to invest over CHF100m to
create a campus of excellence in Geneva with a world-class
research facility by 2020. In parallel, to support its
international growth, Firmenich opened new facilities in
Nigeria, Korea, Mexico, Singapore and the United States this
year.

Firmenichs growth was fueled by
leading innovation and creativity in many ways this year.

In line with the United Nations
Sustainable Development Goals (UN SDGs) and its commitment
to the United Nations Global Compacts 10 principles,
Firmenich put its innovation to work to address key societal
challenges, such as hygiene and sanitation, health and
nutrition, and climate change.

To address todays sanitation
crisis, the Company successfully launched breakthrough
technologies that effectively counter malodor, in
partnership with the Bill & Melinda Gates Foundation, to
reinvent toilets at the base of the pyramid.

To enable responsible nutrition
solutions, Firmenich advanced its leading taste modulation
technologies to reduce sugar, salt, and fat without
compromising on taste. The Company estimates that its
solutions removed 100,000 metric tonnes of sugar, equivalent
to 500 billion calories, from its customers food and
beverage brands this year.

Gaining traction with its pioneering
bio-based ingredients, the Group reached significant growth
with its latest molecule Ambrox® Super, building on the
success of Clearwood®. Beyond their unique olfactive
profiles, these molecules deliver optimized environmental
performances.

Strengthening its prestigious circle of
world-class creators, Firmenich proudly appointed two
perfumers, Nathalie Lorson and Tony Reichert, as Master
Perfumers, recognizing their iconic body of work and legacy
in developing the Companys next generation of talent.

The Groups creativity was further
celebrated by the industry this year when Harry
Frémont was honored with the Fragrance
Foundations Lifetime Achievement Award. In France,
Perfumer Fabrice Pellegrin was named Perfumer of the Year by
Cosmétiquemag for his best-selling creations and
mastery of Firmenichs natural ingredients.

Recognizing the Groups leadership
in responsible sourcing in Indonesia, Firmenich was honored
to receive the countrys Presidential Award,
acknowledging its positive impact in enhancing the
livelihoods of patchouli farming communities.

The Group acquired a majority stake in
Essex Laboratories this year to lead in natural mint
solutions. With a common commitment to responsible sourcing,
Firmenich and Essex combine their unique innovation to
deliver top-quality sustainable and traceable mint.

To build the most sustainable and
traceable value chain for its natural ingredients, Firmenich
hosted its third Naturals Together event in Singapore.
Working hand in hand with its partners at the source, key
experts, and customers, the Company harvests its most
pristine ingredients from nature sustainably.

T.
Hasegawa Full Year 2016-2017 Sales
Results - September 30, 2017 - T.
Hasegawa's consolidated net sales were up 0.9% to ¥
48,001 million compared to ¥ 47,591 million in the
prior year. Net income for the period was up 18.2% to ¥
4,299 million.

Human
perception goes digital at the Campus of the Senses in
Erlangen- 1 September, 2017 - Future
multisensory digital systems will have the ability to
understand and simulate human sensory perception. The aim of
the Campus of the Senses in Erlangen is to conduct
fundamental research into the digitalization of human
sensory experiences and to derive new technologies and
services from this knowledge. Future multisensory digital
systems will have the ability to understand and simulate
human sensory perception. The aim of the Campus of the
Senses in Erlangen is to conduct fundamental research into
the digitalization of human sensory experiences and to
derive new technologies and services from this knowledge.
The Campus of the Senses is a joint initiative of the
Fraunhofer Institutes IIS and IVV in cooperation with
Friedrich-Alexander-Universität Erlangen-Nürnberg
(FAU).

The trend toward digitalization, until
now mostly associated with industry, is increasingly
spreading to all other areas of life, including
peoples everyday activities. The Campus of the Senses
in Erlangen intends to digitally recreate human senses such
as sight and hearing, and especially the chemical senses of
taste and smell. For instance, machines could be designed to
help people who have lost their sense of taste and smell due
to an infection determine whether food has gone
bad.

Our understanding of the complex
processes of human sensory perception is still relatively
limited, and many questions remain unanswered. How do the
different senses interact? Do people react differently to
movies if they are simultaneously exposed to contradictory
smells? Will I experience less stress at work if disturbing
odors are replaced by more pleasant ones?

Everyday help for people
with impaired sensory perception

Many of the neurological processes
involved in taste and smell perception are unconscious. With
the support of machines, it might be possible to enhance
peoples conscious awareness of their environment, and
hence enable them to respond more appropriately to possible
risks and dangers. The challenge lies in designing machines
capable of recording and interpreting human sensory
perceptions and transforming them into digital form. The
Campus of the Senses addresses precisely these
topics.

The Campus of the Senses in Erlangen adds
new sense to the digital transformation of
businesses

Established companies and startups in
almost any sector of business are invited to work together
with the Campus of the Senses in Erlangen. With the support
of research partners, they can use the facilities to develop
new methods and technologies for collecting and interpreting
empirical data on the human senses and sensory perceptions,
including the development of sensory aids and the analysis
of human responses to sensory stimuli.

Human-centered research
in Erlangen

The planned infrastructure of the Campus
of the Senses in Erlangen consists of three laboratories,
each focusing on a different area of research, coordinated
by a central office. Scientists with expertise in many
different areas, including engineering, medicine, chemistry
and neuroscience, can work here hand in hand to build
knowledge, develop interdisciplinary expertise, and promote
technology transfer in the field of sensory research and
development. This will create new opportunities for
scientific leadership: From the development of intelligent
sensors and algorithms to extended man-machine interfaces
and multi-sensory systems for stimulation.

The long-term goal of the Campus of the
Senses in Erlangen is to secure Germanys
competitiveness by reinforcing its pioneering, international
role in the field of the digitalization of the
senses.

The campus will be built up over a period
of five years, during which the central office will be
established and the various laboratories and the technical
infrastructure will go into operation. More importantly, a
platform for joint creative research projects will be
established to allow new methods and technologies to be
developed beyond the confines of traditional scientific
disciplines.

The Campus of the Senses in Erlangen is a
joint initiative of the Fraunhofer Institutes IIS and IVV in
cooperation with Friedrich-Alexander-Universität
Erlangen-Nürnberg (FAU). The kick-off will be held at
Fraunhofer IIS in Erlangen on September 15, 2017.

Should you have questions or require
further information, please feel free to contact us. For
current and archived news and events, please visit
www.iis.fraunhofer.de/press. Kind regards, Thoralf Dietz,
Head of Corporate Communications

Evolva
announces major
restructuring- 30 August 2017  EvolvaEvolva
announced in its half year results further details of its
future intended strategic direction to aggressively grow
product revenues and accelerate the path to a cash flow
break-even position. In order to exploit the full potential
of its own products in various applications and geographies,
the company will enter commercial collaborations with market
leading companies in addition to selected direct sales. It
will also maintain a capital-light manufacturing strategy
and continue to strengthen its unique and highly
differentiated technological capabilities. Together, we
believe these elements will generate significant shareholder
value.Evolva has undertaken a review of its
operational structure to best fit its goals, details of
which are announced below.Evolva will undertake a major site
consolidation over the coming months, centralizing research
and development activities predominantly at its Reinach
headquarters in Switzerland. This will also allow the
company to gain maximum synergies across all its products
and pipeline programs, to simplify and reduce back office
processes, and to reduce facility costs.As a consequence, Evolva is changing its
management structure. The first phase of this transformation
has already been announced with the appointment of a new
Chief Executive Officer, Simon Waddington, and a new Chief
Commercial Officer, Scott Fabro. Today we announce the
second phase with the departure of 3 members of the Group
Management Team (GMT).Evolva Chief Business Officer Pascal
Longchamp, Chief Scientific Officer Jørgen Hansen and
Managing Director & CEO of Evolva India Panchapagesa
Murali will step down from the companys GMT by or
before the end of the year while providing support to the
transition process. The CEO will lead R&D on an interim
basis during the search for a Chief Technology Officer, a
process that has been initiated. Panchapagesa Murali will
aim to spin off Evolvas Chennai branch into an
independent R&D services group in the course of Q4 of
this year.Evolva will reduce its overall headcount
from currently 178 (FTEs) to approximately 100. We
anticipate that Evolvas annual operating expenses run
rate will decrease by approximately 30% or roughly CHF 11
million developing full effect in Q2 of 2018. Evolva will
take a one-time charge in 2017 against its Profit and Loss
Statement of around CHF 5 million and estimates capital
expenditures for the centralization of its laboratories and
small-scale fermentation equipment to equal around CHF 1
million with the majority being spent in Q4 2017. Guidance
on product revenues, which we estimate will more than triple
in 2017 over 2016, will not be affected by the
restructuring.Evolva CEO Simon Waddington said,
Evolva is undertaking the next logical step in its own
evolution. Both our leadership and operations will be
significantly optimized to ensure that our products achieve
their full potential and our innovation engine remains
strong. The choices we make today will strengthen our
ability to deliver commercial success, realize future
innovation breakthroughs, and produce shareholder value. I
would also like to personally thank all employees as well as
our departing management team members, Pascal Longchamp,
Jørgen Hansen and Panchapagesa Murali, for their
invaluable contributions to Evolva over many
years.

Frutarom
1st Half Qtr 2017 Sales- Haifa, Israel  August 17,
2017 - In First Half 2017: Sales grew 15.8% to a record US$
646.1 million with a Pro-forma
constant currency growth of 6.1%- Sales from core activities grew 15.6% to a
record US$ 601.8 million with a
Pro-forma constant currency growth of 7.1%- Sales from Flavor activities grew 16.4% to
a record US$ 473.6 million. with a Pro-forma constant currency growth of
6.3%- Sales from Specialty Fine Ingredients
activities grew 13% to a record US$ 133.2 million with a
Pro-forma constant currency growth of 10.8%- Record-level profits: Gross profit grew by
16.2% to US$ 247.9 million;- EBITDA grew by 29.3% to US$ 122.6
million;- Net income grew by 36.9% to US$ 70.9
million;- Earnings per share grew by 36%2d 2017 Qtr sales grew 14.4% to a record US$
343.6 million. 2d Qtr Pro-forma constant currency growth was
6.8%.

McCormick &
Company Inc. (NYSE: MKC), a global
leader in flavor, today announced that it has signed a
definitive agreement to acquire Reckitt Benckisers
Food Division (RB Foods) from Reckitt Benckiser
Group plc (RB) for $4.2 billion, subject to
certain customary purchase price adjustments.

Sensient
Flavors & Fragrances Group 1st Half 2017
Sales-
Milwaukee, July 20, 2017 - The Flavors & Fragrances
Group reported revenue of $185.6 million and $209.5 million
in the second quarters of 2017 and 2016, respectively.
Operating income was $28.5 million, in the quarter compared
to $35.5 million in last years quarter. The results
from last years second quarter included a $2.7 million
benefit from the sale of an import right. The Group was also
impacted by operational issues related to the wind-down of
restructuring activities which were largely completed during
the quarter. Foreign currency translation reduced revenue
and operating income by approximately 2% and 1%,
respectively, in the quarter.

In the first six months of 2017, the
Flavors & Fragrances Group reported revenue of $372.4
million compared to $408.0 million in the first six months
of 2016. Segment operating income was $57.3 million in the
first six months of 2017 and $63.1 million in the first six
months of 2016. Foreign currency translation reduced revenue
and operating income by approximately 2% and 1%,
respectively, in the first six months of 2017.

Givaudan
2017 Half year results- 20 July 2017 - Givaudan Group sales
for the first six months of the year were CHF 2,483 million,
an increase of 2.3% on a like-for-like basis and 6.4% in
Swiss francs. Fragrance Division sales were CHF 1,137
million, an increase of 0.1% on a like-for-like basis and
0.4% in Swiss francs. Flavour Division sales were CHF 1,346
million, an increase of 4.4% on a like-for-like basis and
12.0% in Swiss francs. Net income for the first six months
of 2017 was CHF 384 million compared to CHF 368 million in
2016, an increase of 4.5%. This results in a net profit
margin of 15.5% versus 15.7% in 2016. Basic earnings per
share were CHF 41.70 versus CHF 40.00 for the same period in
2016.

Givaudan
to acquire Vika B.V.- 11 July 2017 - Givaudan today
announced that it is acquiring Vika B.V. to strengthen its
portfolio of natural dairy solutions. Vika B.V. offers a
range of natural dairy ingredients, fonds and stocks, as
well as meat and plant based extracts to customers in the
food and beverage industry. With headquarters in the
Netherlands, Vika has also facilities in Belgium, the UK,
and New Zealand, employing globally over 200 employees.
While terms of the deal have not been disclosed, Vikas
business would have represented approximately EUR 64 million
of incremental sales to Givaudans results in 2016 on a
proforma basis. Givaudan plans to fund the transaction from
existing resources. The planned acquisition remains subject
to formal approvals from the relevant antitrust authorities.
The transaction is expected to close in the second half of
2017.

Neil
Goldsmith is out as CEO and Board member of
Evolva- 6 July 2017  Evolva today
announces the departure of CEO Neil Goldsmith and his
succession by the current Chief Operating Officer (COO),
Simon Waddington. Since co-founding Evolva, Neil Goldsmith
has been instrumental in Evolvas development over the
last thirteen years, moving the company from a
pharmaceutical oriented biotech start-up to a listed
business developing and selling specialty ingredients for
health, wellness and nutrition markets. Neils
entrepreneurial approach has led to the launch by Evolva of
products such as nootkatone and resveratrol, and the
advancement of best-tasting stevia products to an
anticipated launch in 2018, as communicated earlier this
year.

Evolvas Board and executive
management have recently determined that the near-term focus
needs to be on growing the market opportunity for
Evolvas products and delivering attractive margins.
This more focused approach is not a natural fit with
Neils entrepreneurial strengths, something recognised
by both Neil and the Board. As a consequence Neil and the
Board have mutually agreed that Neil will step down as CEO
and member of the Evolva Board with immediate
effect.

Neil will be succeeded by Simon
Waddington, currently COO of Evolva. Simon had previously
been the CEO of Abunda Inc. until its acquisition by Evolva
in 2011 upon which he joined the management team. His
background and experience is ideally suited to the next
phase of Evolvas evolution.

Firmenich
to Acquire Agilex
Fragrances- Geneva, Switzerland, June 14th,
2017  Firmenich today announced that it is acquiring
Agilex Fragrances, a leading fragrance company in North
America serving mid-sized customers. Headquartered in
Piscataway, New Jersey, U.S.A, Agilex Fragrances is
recognized for its impressive track record in designing
creative fragrances, as well as its industry-leading supply
chain with best-in-class speed-to-market. Furthering its
operational excellence, the Group recently launched a new,
state-of-the-art manufacturing center in Somerset County,
New Jersey with highly automated and flexible processes.
I am delighted to be welcoming Agilex Fragrances
within the Firmenich Group, said Patrick Firmenich,
Chairman of the Board, Firmenich. With their
established customer base, recognized best-in-class service
levels and proven operational excellence for mid-sized
customers in North America, they perfectly complement our
Fragrance business. By joining the Firmenich
Group, with its global reach and cutting edge creativity and
research, we will take our company to new heights,
commented Ray Hughes, CEO, Agilex Fragrances. Our
shared ambition is to design unique fragrances for our
customers while furthering our industry-leading agility and
speed-to-market.

Agilexs fit-for-purpose
business model is a winning blueprint to serve mid-sized
businesses, combining proprietary, tailored solutions with
an agile service model, added Gilbert Ghostine, CEO
Firmenich. I look forward to seeing how our global
creativity and innovation capabilities, as well as, consumer
understanding will open up new opportunities for Agilex and
their customers.

Upon closing, Agilex Fragrances will be
operating as a stand-alone entity and will continue to
design world-class fragrance solutions for mid-sized
customers. With the new manufacturing centers latest
automated compounding technology and flexible processes,
Agilex Fragrances will take its innovation and turnaround
times to new levels of excellence.

Financial terms of the deal have not been
disclosed. The completion of this transaction is subject to
clearance by the relevant regulatory authorities and is
expected to close prior to year-end 2017.

Firmenich
appoints Julien Firmenich as Head of
Ingredients- Geneva, Switzerland, June 12th,
2017  irmenich is pleased to announce the appointment
of Julien Firmenich as Vice President Sales, Ingredients. In
this role, he will lead the Ingredients Business Unit with a
focus on breakthrough innovation, creativity and long term
value creation. Based in Geneva, he will report directly to
Armand de Villoutreys, President of Perfumery &
Ingredients effective July 1st.

Frutarom
1st Qtr 2017 Sales- Haifa, Israel  May 24, 2017 -
Frutaroms sales in the first quarter of 2017 rose
17.4% to a record US$ 302.5 million compared with US$ 257.7
million in the parallel period, reflecting 5.3%
year-over-year growth on a pro-forma and constant currency
basis. Changes in the exchange rates of currencies in which
the Company operates as against the US dollar had a 0.4%
negative impact on sales growth in pro-forma terms compared
with Q1 2016. Sales for Frutaroms core activities
(Flavors activity and Specialty Fine Ingredients activity)
rose 17.7% in Q1 2017 to reach a record level US$ 283.5
million compared with US$ 240.8 million in the same quarter
last year, reflecting 6.6% year-over-year growth on a
pro-forma and constant currency basis. Changes in exchange
rates had a negative 1.0% impact on results in pro-forma
terms. Sales for Flavors rose 20.3% in Q1 2017 to reach US$
219.4 million in Q1 2017 as against US$182.4 million in Q1
2016, reflecting 6.6% year-over-year growth on a pro-forma
and constant currency basis. Currency effects negatively
impacted results in pro-forma terms by 0.9%. Sales for
Specialty Fine Ingredients rose 10.8% to US$ 66.8 million in
Q1 2017 compared with US$ 60.2 million in Q1 2016 and
reflect 7.6% year-over-year growth on a pro-forma and
constant currency basis. Currency effects negatively
impacted sales by 1.3% in pro-forma terms. In Q1 2017
Frutarom achieved record quarterly results in sales, gross
profit, operating profit, EBITDA, net income, earnings per
share and cash flow from operating activities. These record
results were achieved thanks to the profitable internal
growth combined with the acquisitions made and the beginning
of contributions from the merger activities and efficiency
measures. Gross profit for core businesses (which include
the Flavors activity and the Specialty Fine Ingredients
activity) rose 17.1% to reach US$ 111.6 million (gross
margin of 39.4%) in Q1 2017 as compared with US$ 95.3
million (gross margin of 39.6%) in Q1 2016. Adjusted for
non-recurring expenses, gross profit for core businesses
rose 16.1% to reach US$ 112.4 million (gross margin of
39.6%) as compared with US$ 96.8 million (gross margin of
40.2%) in Q1 2016. Operating profit for core businesses rose
50.1% to reach US$ 44.8 million (operating margin of 15.8%)
in Q1 2017 as compared with US$ 29.9 million (gross margin
of 12.4%) in Q1 2016. Adjusted for non-recurring expenses,
operating profit for core businesses rose 23.8% to reach US$
45.6 million (operating margin of 16.1%) as compared with
US$ 36.9 million (operating margin of 15.3%) in Q1 2016.

Senomyx
Confirms Previously Announced Results of 2017 Annual
Meeting- May 22, 2017 - Senomyx, Inc. today
confirmed that Senomyx shareholders voted in accordance with
the Companys recommendation to re-elect the full Board
at the Companys 2017 Annual Meeting of Shareholders
(Annual Meeting) held on May 11, 2017. The
Concerned Shareholders and Nominees of Senomyx
(CSNS) group has acknowledged that a quorum was
present at the 2017 Annual Meeting and that the
Companys nominees were duly re-elected to the Board.
The CSNS group has withdrawn its nominations and proxy
contest effective immediately, and has agreed to a customary
three-year standstill with the Company.

Takasago
Full Year 2016-2017 Sales - May
15, 2017 - Takasago sales declined 3.5% to ¥ 136,764
million from ¥ 141,660 in the prior year ending March
31. Net income increased 29.7% to ¥ 6,327 million from
¥ 4,880 million in the prior year.

Symrise
1st Qtr 2017 Sales- May 9, 2017 - The Symrise Group
generated sales of € 765.2 million in the first quarter (Q1
2016: € 731.8 million). This represents an increase of 4.6 %
in reporting currency compared to the first quarter of 2016.
Adjusted for portfolio effects, in particular the sale of
Pinova Inc. in December 2016, and for exchange rate effects,
Group sales increased organically by 5.3 %. The Scent &
Care segment achieved sales of € 333.2 million in the first
quarter (Q1 2016: € 344.3 million). Due to the sale of
Pinova Inc. in December 2016, sales decreased by 3.2 %
compared to the prior-year quarter. Adjusted for portfolio
effects from the Pinova sale, the segment recorded organic
growth of 1.1 %. After adjustment for the Pinova portfolio
effect, the Aroma Molecules division posted the strongest
first-quarter sales growth within the Scent & Care
segment. Growth drivers were in particular the high demand
for fragrance ingredients and menthol. The Flavor segment,
which includes aroma applications, generated sales of €
270.2 million (Q1 2016: € 250.2 million). This represents an
increase of 8.0 % as compared to the prior-year quarter.
Organic growth stood at 8.8 %. The Nutrition segment, which
includes the Diana division, with applications for foods,
pet food and baby food as well as probiotics, achieved
strong growth and a 17.8 % increase in sales to € 161.8
million (Q1 2016: € 137.3 million). Excluding portfolio
effects, the segment experienced an organic sales increase
of 9.6 %.

IFF
1st Qtr 2017 Sales- May 9, 2017 - Reported net sales
for the first quarter totaled $828.3 million, an increase of
6% from $783.3 million for the first quarter of 2016.
Excluding the impact of foreign exchange, currency neutral
sales increased 7% over the prior year, including
approximately five percentage points related to our recent
acquisitions. Reported operating profit for the first
quarter was $137.4 million versus $169.9 million reported in
2016. Excluding the impact of foreign exchange and those
items that affect comparability, currency neutral adjusted
operating profit grew 3% as acquisitions, volume growth, and
cost savings initiatives more than offset unfavorable price
to input costs as well as unplanned expenses, including
unfavorable manufacturing variances, bad debt, a product
recall and a litigation loss. Net income declined 2% to
$115.8 million. Fragrances Business Unit - On a
reported basis, sales increased 3%, or $11.3 million, to
$422.1 million. Currency neutral sales also improved 3% led
by growth in Fine Fragrances, Fabric Care and Fragrance
Ingredients. Fine Fragrances improved 10% on a reported
basis and on a currency neutral basis, inclusive of
additional sales related to the acquisition of Fragrance
Resources. Consumer Fragrances increased 1% on a reported
and 2% on a currency neutral basis, principally driven by
the additional sales related to the acquisition of Fragrance
Resources and low single-digit growth in Fabric Care.
Fragrance Ingredients grew 1% on a reported basis and 2% on
a currency neutral basis. Fragrances segment profit
decreased 8% on a reported basis and 6% on a currency
neutral basis, as volume growth and the benefits from
productivity initiatives were more than offset by
unfavorable price to input costs, as well as several
unplanned expenses. Flavors Business Unit - On a
reported basis, sales increased 9%, or $33.7 million, to
$406.2 million, while currency neutral sales grew 10% with
broad-based organic growth across all regions, as well as
the contribution of sales related to the David Michael
acquisition. Flavors segment profit grew 7% on a reported
basis and 12% on a currency neutral basis, led by volume
growth, the benefits from productivity initiatives and the
contribution of the David Michael acquisition.

Senomyx,
Inc. Proxy - Annual Meeting is May 11, 2017- As control of
the Senomyx Board of Directors is being challenged by a
group of Dissident Nominating Stockholders
(which dissidents have purchased less than 0.00001%, of
Senomyx outstanding common stock) it should be an
interesting meeting. Senomyx has
been a pioneer in our scientific knowledge of taste and odor
receptors - as well as developing sweetness and savory taste
and cooling modulators.

Sensient
1St Qtr 2017 Sales-
Milwaukee, April 26, 2017 - For the 1st Qtr 2017, the
Sensient Flavors & Fragrances Group reported revenue of
$186.9 million, a decrease of approximately 5.8% from the
$198.5 million in 2016. 1st Qtr Operating income increased
to $28.8 million in 2017, from $27.6 million in 2016.
Certain restructuring and other costs ocurred in this
years first quarter principally related to non-cash
losses from the divestitures of a European savory ingredient
facility and certain related business lines, and the
Companys European Natural Ingredients business, which
primarily sells dehydrated vegetables. It should be noted
that the above sales figures may include items not normally
considered Flavors & Fragrances - mainly natural
ingredients such as dehydrated vegetables, which
historically have been about 18%+ of reported
sales.

Givaudan
2017 1st Qtr Sales- Geneva, 11 April 2017 - In the
first three months of 2017, Givaudan recorded sales of CHF
1,242 million, an increase of 3.5% on a like-for-like basis,
and 7.7% in Swiss francs compared to the previous year. The
Fragrance Division recorded sales of CHF 576 million, a
growth of 2.1% on a like-for-like basis and an increase of
2.6% in Swiss francs. The Flavour Division reported sales of
CHF 666 million, a growth of 4.8% on a like-for-like basis
and an increase of 12.6% in Swiss francs. Including
Spicetec, acquired in August 2016 and Activ International,
acquired in January 2017, the growth was 14.1% in local
currency.

Huabao
International Holdings Limited- April 10, 2017 - Huabao
International Holdings Limited (the Company)
announced the approval of the spin-off of Huabao Flavours
& Fragrances Co. Ltd. Huabao Flavours & Fragrances
Co. Ltd., a 90.21% indirect non-wholly owned subsidiary of
the Company, will have a separate listing of the shares of
the Spin-off Company on The Shenzhen Stock
Exchange.

IFF
Acquiers PowderPure- April 10, 2017 - International
Flavors & Fragrances announced that it had acquired
Columbia Phytotechnology LLC, a/k/a PowderPure on April 7,
2017. Founded in the early 2000s and based in Oregon,
PowderPure utilizes its patented Infidri drying
technology to create all-natural food ingredients by
eliminating water while leaving the taste, nutrition and
color matrix intact. Using minimal processing, PowderPure
currently focuses on whole fruits and vegetable powders,
juice powders, as well as other specialty products.
Financial terms of the deal have not been disclosed.

In
Memorium - Barney J. Kane- Bernard (Barney) James Kane, Jr.
passed away at his home in Atlantic Beach, Florida on
Monday, March 27, 2017. Following graduation with a BS degree from
Iona College and a Masters degree in organic chemistry at
Adelphi University, in 1957, Barney accepted a position as a
Research Chemist at the Naval Stores Division of the Glidden
Company in Jacksonville Fla, (now part of Symrise). Over his
forty-one years of service, he wrote numerous papers, was
awarded 29 patents and made many other valuable
contributions to make the company a major supplier of flavor
& fragrance ingredients. Barney retired in February,
1998. Because of his efforts, the companys
Jacksonville research facility was renamed, the
Bernard J. Kane Laboratory. He is survived
by his wife, Marianna. A Funeral Mass will be celebrated at
1:00 p.m., Saturday, April 1st at St. Pauls Catholic
Church of Jacksonville Beach, FL.

Frutarom
Full Year 2016 Sales- Haifa, Israel  March 23, 2017
- Frutarom's 2016 sales rose 31.4% to a record US$ 1,147
million of which we consider US$ 1,1074.4 million to be
F&F related. Constant currency growth on a pro-forma
basis was 5.3%. Sales for Frutaroms core activities
(Flavors activity and Specialty Fine Ingredients activity)
rose in 2016 by 35.4% to reach a record US$ 1,067.5 million
compared with US$ 788.5 million last year, reflecting
constant-currency growth on a pro-forma basis of 5.9%. Sales
in the field of Flavors in 2016 as reported in US dollars
rose 39.3% to reach US$ 846.5 million (compared with US$
607.5 million the previous year), reflecting
constant-currency growth on a pro-forma basis of 6.1%
compared to 2015. pro-forma basis by 5.3%. Frutaroms
reported sales in fourth quarter 2016 rose 28.1% to reach a
Q4 record of US$ 289 million compared with US$ 225.6 million
in the same quarter the previous year. Sales for
Frutaroms core activities (Flavors activity and
Specialty Fine Ingredients activity) in fourth quarter 2016
rose 30.4% to reach a record US$ 267 million compared with
US$ 204.8 million in the parallel quarter last year. Sales
in the field of Flavors in fourth quarter 2016 as reported
in US dollars rose 36.9% to reach US$ 214.8 million compared
with US$ 156.9 million the previous year. Sales in the field
of Specialty Fine Ingredients in fourth quarter 2016 as
reported in US dollars rose 11.5% to reach US$ 53.9 million
compared with US$ 48.3 million the previous year.

Mane
- Full Year 2016 Sales increase -
March 14, 2017 - Mane achieved salesof€1,058 million (+11.7%) in 2016 vs € 947.6
million in 2015, which translateS to USD $1,172 million
for the year 2016 (at an average exchange rate of 1 Euro =
1.1073 U.S. $). Sales growth was +14.4% in local currencies.
(personal communication).

Symrise
reports strong sales and earnings growth in
2016- March 14, 2017 - Symrise benefited
from robust demand across all regions and segments in 2016.
Sales increased by 12 % year-on-year in reporting currency
to € 2,903.2 million (2015: € 2,601.7 million). In local
currencies, the increase amounted to 16 %. Normalized net
income grew to € 265.9 million (2015: € 246.8 million) which
represents an increase of 8 %.

Excluding portfolio effects from
acquisitions in the areas of fragrances and nutrition and
from the divestment of Pinovas industrial activities,
organic sales growth in local currency amounted to 8 %. As a
result, Symrise posted substantially stronger growth than
the relevant market for flavors and fragrances, which grew
around 3 % for 2016 according to market estimates. The
activities of the former Flavor & Nutrition segment are
now carried out by two separate segments. The Flavor segment
includes applications for beverages, savory products, and
sweets. The Nutrition segment comprises the Diana division
with the application areas of food, pet food, Aqua and
Probi. Scent & Care continues to combine the areas of
fragrances, cosmetic ingredients and aroma molecules.
Fragrances, with its application fields of fine fragrances,
personal care, oral care and home care, was reorganized into
global units in 2016.

Sales in Scent & Care increased from
€ 1,073.7 million to € 1,311.3 million. This represents a
plus of 25 % in local currency. At reporting currency, sales
grew by 22 %. Excluding the effects from Pinova, sales were
up 5 % in local currency.

Sales in the Flavor segment increased by
4 % to € 1,015.9 million (2015: € 980.2 million). In local
currency, sales grew by 10 %.

In total, combined F&F sales from the
Flavor segment and Scent & Care were 2,089.6 million
euros.

Robertet
Full Year 2016 Sales - February
24, 2017 - The Board of Directors of Robertet met in Grasse
on 22 February 2017 under the chairmanship of Philippe
Maubert and reviewed the Group's activity and provisional
results for the financial year 2016. Consolidated revenue
for the year ended 31 December 2016 was € 468 million, an
increase of 7.6% compared to 2015. This turnover was 85%
outside France and is growing in Europe, South America and
Asia. The Raw Materials (+5%), Perfumery (+10 3%) and Flavor
(+6.7%) divisions are all growing. Consolidated net profit,
unaudited, is in the order of € 41 million, an increase of
13%, higher than forecast. Activity at the beginning of 2017
is well oriented, growing more than in the second half of
2016.

IFF
Full Year 2016 Sales- February 15, 2017 - IFF's full year
net sales for 2016 were $3,116.4 million an increase of 3.1%
over 2015. 4th Qtr net sales increased 6.6% to $762.6
million. Currency neutral sales increased 5% over the prior
year, including approximately two percentage points related
to recent acquisitions. On a reported basis, full year
Flavor sales increased 4%, or $53.6 million, to $1.5
billion, while currency neutral sales grew 6% driven by
growth in all categories, and the contribution of sales
related to the Ottens Flavors and David Michael
acquisitions. On a reported basis, full year Fragrance sales
increased 3%, or $39.6 million, to $1.6 billion, while
currency neutral sales improved 4%, with two percentage
points of growth contribution from the organic business and
two percentage points related to the acquisition of IFF |
Lucas Meyer Cosmetics.

William
J. Bill Downey Jr. has passed
away - January 30, 2016 - Bill
was a pioneer of the Society of Flavor Chemists, and was
President in 1966/67 and was an active FEMA Board member. He
will be remembered not only as a creative flavorist, but as
a scientist that helped lay the foundation of the modern
flavor & fragrance industry. Above all he was a
Quintessential Gentleman that helped all that knew
him.

Takasago
9 Month 2016-2017 Sales -
February 13, 2017 - Takasago 9 Month sales for the period
ending December 31, 2016 were ¥ 105,560 million, a
decrease of 2.0% over the prior year period. Operating
income increased 12.3% to ¥ 6,916 million. Net income
increased 22% to ¥ 6,199 million.

Sensient
F&F Full Year 2016 Sales-
Milwaukee, Feb. 09, 2017 - For the full year 2016, the
Sensient Flavors & Fragrances Group reported revenue of
$795.3 million, a decrease of approximately 3% from the
$819.0 million reported in 2015. Operating income increased
to $123.5 million in 2016, from $121.9 million in 2015. The
Flavors & Fragrances Group reported revenue of $186.9
million and $201.0 million in the fourth quarters of 2016
and 2015, respectively. Operating income increased
approximately 3% to $28.4 million, from $27.5 million in
last years fourth quarter. It should be noted that
the above sales figures include items not normally
considered Flavors & Fragrances - mainly natural
ingredients such as dehydrated vegetables, which
historically have been about 18%+ of reported sales.
Excluding the "Natural Ingredients" segment, "Tradional
Flavor and Fragrance" sales were $653.8 million in 2016, a
decline of 2.1% from 667.9 million in 2015.

T.
Hasegawa 1st Qtr 2016-2017 Sales
Results - February 3, 2017 -
Sales for the 1st Qtr 2016-2017 period ending Dec. 31, 2016
were up 3.0% to ¥ 11,542 million compared to ¥
11,209 million in the prior year. Net income for the period
increased 63.5% to ¥ 1,166 million.

Givaudan
Full Year 2016 Sales- Geneva, 31 January 2017 - Givaudan
Group full year sales were CHF 4,663 million, an increase of
4.2% on a like-for-like basis and 6.1% in Swiss francs when
compared to 2015. Fragrance Division sales were CHF 2,230
million, an increase of 5.6% on a like-for-like basis and
6.4% in Swiss francs. Flavour Division sales were CHF 2,433
million, an increase of 3.0% on a like-for-like basis and
5.8% in Swiss francs. The gross margin declined to 45.6%
from 46.2% in 2015, mainly as a result of the lower gross
margin on the acquired Spicetec Flavors business. Net income
increased to CHF 644 million in 2016 from CHF 625 million in
2015, an increase of 3.1%. This results in a net profit
margin of 13.8%, versus 14.2% in 2015. Basic earnings per
share increased to CHF 69.95 versus CHF 67.89 for the same
period in 2015.

Givaudan
acquires Activ International - 17
Jan 2017 - As part of its 2020 strategy to strengthen
capabilities in natural flavour solutions to its customers,
Givaudan today announced that it has acquired Activ
International.

While terms of the deal have not been
disclosed, Activs business would have represented
approximately CHF 40 million of incremental sales to
Givaudans results in 2016 on a proforma basis.
Givaudan plans to fund the transaction from existing
resources.

Firmenich
announces historic investment in
Geneva -
January 11th 2017  Firmenich
announces the sale of its La Jonction site in Geneva to the
States Pension Fund in support of the Geneva
states urban renewal plan. The transaction will enable
Firmenich to conduct its largest investment ever in Geneva,
to strengthen and expand its global center for innovation
and creation. By 2020, the fragrance and flavors company
will invest more than 100 million Swiss francs to transfer
all its research and development and creation and support
functions, from La Jonction to a new Meyrin-Satigny campus
of excellence. Today, La Jonction is home to
Firmenichs most important research and development
center worldwide, employing 500 employees who represent 65%
of its Research and 85% of its Intellectual Property
creation. The site is also one of its main creation centers
bringing together an exceptional team of world-renowned
Perfumers and Flavorists. From this center of excellence,
Firmenichs creators and researchers work alongside
leading sales teams to ensure the global reach of its
cutting-edge technologies and creations. Firmenich expects
to transfer all activities, including all support functions
from La Jonction to Meyrin-Satigny by 2020, once the Campus
has been completed.

Senomyx
has Announced a Restructuring
Plan - On December 2, 2016,
Senomyx, Inc. implemented a restructuring plan wherein the
Company expects to reduce the Companys work force by
17 full-time equivalent employees. The Company expects to
substantially complete the Plan in the fourth quarter of
2016. Under the Plan, with the resulting staff and other
expense reductions, the Company expects to reduce its
expenses by approximately $4 million on an annualized basis.
The Company expects to record restructuring-related expenses
totaling approximately $490,000 related to termination
benefit costs and other costs associated with the Plan.
Implementation of the Plan reflects the shift in the
Companys priorities to focus its sweet taste research
and development efforts primarily on natural sweet taste
modifiers and natural high intensity sweeteners. The Company
will continue to invest in its salt taste program utilizing
a focused research and development approach. Both the
natural sweet program and salt taste program are supported
by funding under collaborations. In addition, the Company
will continue to invest in its commercialization initiatives
including direct sales and activities supporting its
collaborators commercialization of the Companys
flavor ingredients.

Huaboa
Intl. Half Year 2016-2017 Sales -
November 28, 2016 - Huaboa International net sales for the
half year ending September 30, 2016 were 1,859.5 million
Hong Kong dollars (+9.8%) of which about 70% was from the
flavors & fragrance related segments. The F&F
segments sales decreased 6.1% to 1,302.3 million
HKD

Takasago
Half Year 2016-2017 Sales -
November 17, 2016 - Takasago half year sales for the period
ending September 30, 2016 were ¥ 70,691 million, a
decrease of 2.0% over the prior year period. Operating
income declined 15.4% to ¥ 3,947 million. Net income
declined 18.9% to ¥ 3,290 million. Looking at the
business segments, net sales in the Flavors Business fell
0.4% year on year, to ¥43,075 million, reflecting the
negative impact of the currency fluctuations that offset
sales growth for the U.S. subsidiary. In the Fragrances
Business, net sales fell 8.7% year on year, to ¥18,205
million, due mainly to the poor performance of the
subsidiary in China. In the Aroma Ingredients Business, net
sales fell 1.1%, to ¥5,654 million, despite the solid
performance of menthol, the mainstay product of this
business segment.

T.
Hasegawa Full Year 2015-2016 Sales
Results - November 16, 2016 - for
the 12 months ending September 30, 2016, T. Hasegawa's
consolidated net sales were up 0.8% to ¥ 47,591 million
compared to ¥ 47,228 million in the prior year. Net
income for the period was up 19.5% to ¥ 3,637
million.

IFF
to Acquire Fragrance
Resources
- New York, November 3, 2016 -
International Flavors & Fragrances Inc., a leading
innovator of sensory experiences that move the world, today
announced that it has entered into an agreement to acquire
Fragrance Resources. Founded in 1987, Fragrance Resources is
a privately-held, family-owned fragrance company. For almost
30 years, it has distinguished itself with exceptional
creative talent and quality service to faster-growing
regional customers. The company has facilities in Germany,
North America, France, and China. IFFs Vision
2020 business strategy is well-served with this
highly-complementary bolt-on acquisition, helping us to win
where we compete in key fragrance markets and categories as
we look to accelerate growth, said IFF Chairman and
CEO Andreas Fibig. Nicolas Mirzayantz, Group President,
Fragrances, added Since 1987, the Fragrance Resources
team has been a key player in faster-growing specialty fine
fragrances  an important growth category. The addition
of this outstanding company into the IFF family will help us
strengthen our position in strategic areas and further
penetrate the critical and accelerating regional customer
base that we see as the engine of growth.

Symrise
9 Month 2016 Sales - Holzminden,
Germany - November 2, 2016 - In the first nine months 0f
2016, Symrise increased its sales by 11 % to € 2,192.3
million (9M 2015: € 1,977.0 million). In local currency, the
increase amounted even to 16 %. Both segments had a
substantial impact on this strong performance. Purchased
activities also contributed to sales, including those of the
Pinova Holdings and those of Scelta Umami and Nutra Canada.
Even without these additional contributions, the Group
achieved significant organic sales growth of 8 % in local
currency. Net income for the group was € 193.6
million.

At regional level, Symrise experienced
the strongest growth in Latin America, where sales were up
34 % in local currency. The second-strongest region was
North America, at 27 %. Asia-Pacific saw a 12 % increase in
sales, followed by EAME with an increase of 7 %. Symrise
also recorded strong growth in the Emerging Markets, where
sales were 17 % higher in local currency, accounting for 43
% of the Groups total sales.

Scent & Care sets the course
for the future - Scent & Care, which comprises the
fragrance and cosmetic ingredients activities, increased its
sales, including contributions from the acquisition of
Pinova Group, by 23 % (27 % in local currency) to € 997.2
million (9M 2015: € 812.3 million). The segment posted
strong gains even without the Pinova effects, with an
organic sales increase by 7% at local currency. Scent &
Care reported particularly dynamic demand with cosmetic
active ingredients and fragrances.At operational level,
Symrise used the third quarter to realign the Fragrances
division. In future, rather than being organized by regions,
the business with fragrance compositions will be organized
globally by area of application, namely Fine Fragrances,
Personal Care, Home Care and Oral Care. Moreover, the
division is going to consolidate its capacities. Therefore,
the US-American mixed operation in Chester, NY, will be
closed by the end of the year and a production network at
the location in Branchburg, NJ, will be created.

Flavor & Nutrition - Flavor
& Nutrition achieved a sales growth of 3 %, and was up 9
% in local currency. The segment benefited particularly from
good capacity utilization and strong demand for sweets and
culinary applications. Business in the area of pet food also
continued to grow. Excluding the purchased activities of
Dutch Scelta Umami and Nutra Canada, and adjusted for the
sale of the CAP pork specialties last year, the segment also
posted strong organic growth with an increase of 10 % in
local currency.

Sale of the industrial activities to
French manufacturer DRT - In the course of the ongoing
optimization of its portfolio, Symrise has decided to sell
the industrial activities of the Pinova Holdings. Symrise
will continue to operate the holdings former Renessenz
entity, which was acquired with the takeover. In the past
months, these activities have been fully integrated into the
Aroma Molecules division, securing access to strategically
important natural ingredients. As a result, Symrise will
offer a broader fragrance portfolio for perfume
manufacturing going forward, expanding its market leadership
in this area. The unit, which operates under the brand name
Pinova, with product solutions for technical applications in
adhesives, paint, coatings as well as the tire and
construction industries, will be acquired by DRT. The
purchase price was set to US$ 150.0 million. Estimated sales
for 2016 amount to US$ 111.0 million. The transaction is due
to close at the end of 2016. The industrial applications
have only limited points of reference with Symrises
core business. However, Symrise has secured continued access
to specific raw materials from renewable sources. DRT and
Symrise will cooperate closely in the future under a joint
supply agreement.

Sensient
F&F 9 Month 2016 Sales-
Milwaukee, October 20, 2016 - The Flavors & Fragrances
Group reported revenue of $608.3 million (-1.6%) in the
first 9 months of 2016. Segment operating income was $95.1
million (+0.8%) in the first 9 months of this year compared
to $94.4 million in the prior year. The Flavors &
Fragrances Group reported 3d Qtr revenue of $200.7 million,
a decrease of -3.2% from $207.4 million reported in last
years third quarter. Segment operating income was
$32.3 million compared to $31.4 million in the third quarter
of 2015.

Firmenich
Introduces New Chairman and Board
Members - Geneva, Switzerland,
October 12th, 2016 - Firmenich announces the election of
Patrick Firmenich as Chairman of the Firmenich Board of
Directors, after serving as Vice Chairman since 2014 and
leading the company as CEO for 12 years between 2002 and
2014. He succeeds Yves Boisdron who is retiring from the
Board after a decade in which he significantly contributed
to the success of the Company. Building on his prestigious
international career in specialty chemicals, Yves Boisdron
became Chairman of Firmenich in July 2013, after joining the
Board in 2006 and acting as Vice Chairman and Chairman of
the Governance & Compensation Committee.

Givaudan
9 Month 2016 Sales- Geneva, 10 October 2016 - In the
first nine months of 2016 Givaudan recorded sales of CHF
3,518 million, an increase of 5.1% on a like-for-like basis
and 6.7% in Swiss francs compared to the previous year.
Fragrance Division sales were CHF 1,699 million for the
first nine months of 2016, an increase of 7.5% on a
like-for-like basis and an increase of 8.7% in Swiss francs.
Including Induchem, the growth was 8.6% in local currency.
The sales of Induchem, which was acquired on 31 August 2015,
amounted to CHF 19 million for the first nine months of
2016. Flavour Division sales were CHF 1,819 million during
the first nine months of 2016, an increase of 3.0% on a
like-for-like basis and 5.0% in Swiss francs. Including
Spicetec, the growth was 4.7% in local currency. Spicetec
Flavors & Seasonings contributed CHF 29 million
following the acquisition on 25 July 2016.

Firmenich
Full Year 2015-2016 Sales -
Geneva, Switzerland, October 5th, 2016  Firmenich
posted solid results in its Fiscal Year 2016, which ended
June 30th 2016. The Group achieved CHF 3.2 billion in net
sales, growing +8.2% in local currency and +6.3% in Swiss
Francs.

IFF
to Acquire David Michael,
Inc.
- New York, Sep. 13, 2016 -
International Flavors & Fragrances Inc. announced that
it has entered into an agreement to acquire David Michael
& Company, Incorporated. Founded in 1896, David Michael
is a privately-held flavors company headquartered in
Philadelphia, PA. The Company is well-known in the industry
for its vanilla expertise, strength in the Dairy and
Beverage categories, and relationships with dynamic,
faster-growing middle-market customers. This bolt-on
acquisition of David Michael is another important milestone
in IFFs Vision 2020 business strategy, helping us to
win where we compete in the worlds largest flavors
market as we look to further accelerate growth, said
IFF Chairman and CEO Andreas Fibig. The transaction, funded
from existing resources, is expected to add approximately
$85 million in revenue in 2017. Financial terms of the deal
have not been disclosed. The completion of this transaction
is subject to clearance by the relevant regulatory
authorities and satisfaction of other customary closing
conditions. Until the transaction closes, which is expected
to occur in the fourth quarter of 2016, David Michael and
IFF will operate as separate companies.

Frutarom
Half Year 2016 Sales- Haifa, Israel  August 15,
2016 - Frutarom's sales in the first half of 2016 increased
37.4% to a record US$ 300.2 million. Constant currency
growth in pro-forma terms was 7.2%. Sales from Flavor
activities grew 44.3% to a record US$ 224.4 million
reflecting a constant currency growth in pro-forma terms of
7.7%. Sales from Specialty Fine Ingredients activities grew
39.1% to a record US$ 57.6 million, reflecting constant
currency growth in pro-forma terms of 9.9%. Net income grew
by 22.7% to US$ 33.7 million.

Symrise
1st Half 2016 Sales - Holzminden,
Germany - August 11, 2016 - In the first half of 2016,
Symrise increased its sales by 10 % (local currency: 16 %)
to € 1,462.5 million (H1 2015: € 1,330.8 million). Alongside
the continuing strong demand in the segments, this
development was driven by Pinova Group, which was
consolidated this year. Adjusted for portfolio effects, the
Symrise Group posted an impressive 8 % plus in sales in
local currency. Scent & Care increased its sales by 22 %
(local currency: 27 %) to € 667.8 million (H1 2015: € 546.5
million). The segment benefited in particular from high
capacity utilization in its fragrance and cosmetic
ingredients activities and from strong demand for menthol.
Portfolio effects, such as the integration of Pinova,
contributed € 110.5 million to Group sales. Even without
these effects, Scent & Care achieved significant growth
by 7 % in local currency. Flavor & Nutrition achieved a
1 % increase in sales (local currency: 8 %) to € 794.8
million. As in the previous quarter, growth was driven
particularly by strong demand for savory and beverage
applications as well as pet food.

IFF
1st Half 2016 Sales- New York - August 8, 2016 - IFF 1st
Half sales increased 2.2% to $1,576.8 million from $1,542.4
million in the prior year. 2d quarter sales were up 3.4% to
793.5 million. 1st Half fragrance sales increased 4.0% to
$824.8 million while 1st half flavor sales were nearly flat
(+0.3%) at $752.0 million. 2d Qtr fragrance sales increased
4.8% to 414 million. 2d Qtr flavor sales were $379.5 million
(+1.9%). On a currency neutral basis fragrance sales were up
3% for the half year and flavor sales were up 4%. For the
six months ending June 30th, IFF's net income increased 0.7%
to $235.3 million.

T.
Hasegawa 9 Month 2015-2016 Sales
Results- August 5, 2016 - Sales for the 9
month period ending June 30, 2016 were ¥ 35,486 million
(+ 3.2%) compared to ¥ 34,402 million in the prior
year. Net income for the period increased 15.8% to ¥
2,604 million.

Evolvas
nootkatone enters NIH-sponsored
studiesto
assess its effectiveness against mosquitoes that transmit
Zika virus-
25 July 2016 - Evolva has announced that the US National
Institute of Allergy and Infectious Diseases (NIAID), part
of the National Institutes of Health (NIH), will sponsor
studies to test Evolvas nootkatone against mosquitoes
infected with Zika virus. The study will evaluate nootkatone
in multiple formulations against wild type and
insecticide-resistant mosquitoes that carry the virus. Zika
is one of a number of mosquito-borne viruses, which include
both dengue and chikungunya, that are transmitted by
Aedes aegypti and Aedes albopictus mosquitoes.
The World Health Organisation and the US Centers for Disease
Control and Prevention (CDC) have declared the Zika virus a
public health emergency. Zika is associated with potentially
severe neuropathogenic and neurodevelopmental conditions in
humans.

Editors note* - Nootkatone, along with
p-Menthane diol (PMD) and Patchouli alcohol are important
natural / nature identical flavor & fragrance
constituents that are effective against mosquitos and other
insects. Takasago's PMD (p-Menthane diol) is already one of
the few such CDC
recommended insect repellents
that are safe and effective for use by pregnant and
breastfeeding women.

Sensient
F&F Half Year 2016 Sales-
Milwaukee, July 21, 2016 - The Flavors & Fragrances
Group reported revenue of $407.7 million (-0.7%) in the
first six months of 2016. Segment operating income was $62.8
million (-0.3%) in the first half of this year compared to
$63.0 million in the first six months of 2015. Foreign
currency translation reduced both revenue and segment
operating income by approximately 2% in the first half of
this year. The Flavors & Fragrances Group reported
second quarter revenue of $209.3 million, an increase of
2.3% from $204.6 million reported in last years second
quarter. Segment operating income was $35.3 million compared
to $32.5 million in the second quarter of 2015. Foreign
currency translation reduced revenue and segment operating
income by approximately 1% in the quarter. Several of the
businesses in the Flavors & Fragrances Group delivered
solid results in the quarter, including Fragrances, North
America Savory Flavors, and the Beverage businesses in both
North America and Europe.

T.
Hasegawa Half Year 2015-2016 Sales
Results - June 8, 2016 - Sales
for the half year period ending March 31, 2016 were ¥
22,825 million (+ 4.3%) compared to ¥ 21,879 million in
the prior year. Net income for the period increased 31% to
¥ 1,543 million.

Givaudan
Half Year 2016 Sales- Geneva, 18 July 2016 - Givaudan
Group sales for the first six months of the year were CHF
2,334 million, an increase of 6.2% on a like-for-like basis
and 6.9% in Swiss francs. Fragrance Division sales were CHF
1,132 million, an increase of 9.7% on a like-for-like basis
and 10.7% in Swiss francs. Including Induchem, the growth
was 11.0% in local currency. The sales of Induchem, which
was acquired on 31 August 2015, amounted to CHF 13 million
for the first half of 2016. Total sales for Fragrance
compounds (Fine Fragrances and Consumer Products combined)
increased by 10.4% on a like-for-like basis. In Swiss
francs, sales of compounds increased to CHF 977 million from
CHF 892 million.

Givaudan Flavour Division sales were CHF
1,202 million, an increase of 3.0% on a like-for-like basis
and 3.5% in Swiss francs. The increased sales were
positively impacted by new wins and existing business
expansion in the high growth markets of Argentina and Brazil
in Latin America as well as India, Indonesia, Thailand and
Vietnam in Asia Pacific. The mature markets of Japan, Korea
and Australia delivered good results. Europe and Africa
rebounded in the second quarter despite challenging economic
conditions in Western Europe and Sub-Saharan Africa. North
America results were solid against a strong prior year
comparable. Dairy, Savoury and Snacks contributed to the
overall growth.

IFF
and Unilever launch partnership to improve lives of vetiver
farming communities in Haiti -
July 14, 2016 - IFF and Unilever are partnering to enhance
the livelihoods of smallholder vetiver farmers in Haiti. The
partnership, "Vetiver Together", aims to sustainably improve
food security, increase yields, and diversify income, while
working to support womens empowerment and
environmental conservation. Haiti produces some of the best
vetiver in the world, and many farmers rely on cultivation
of the root for their entire source of income. This follows
the lead of Firmenich
and Givaudan
who have previously launched similar progams in Haiti for
vetiver in the last few years. Symrise
has a similar vetiver program in Madagascar.

Huaboa
Intl. Full Year 2015-2016 Sales -
June 22, 2016 - Huaboa International total sales for the
year ending March 31, 2016 was 3,928.2 million Hong Kong
dollars (-9.2%) of which ~82.5% was from the flavors &
fragrance related segments. The F&F related segment
sales decreased ~4.2% to 3,157.2 million HKD = ~U.S. 407.3
million. Huaboa slightly restated the F&F sales segments
for 2014-2015 to reflect the inclusion of the sale of aroma
raw materials products.

Givaudan
to acquire Spicetec Flavors &
Seasonings- May 24, 2016 - As part of
Givaudan's 2020 strategy to strengthen its integrated
solutions strategies, the company announced the acquisition
of ConAgra Foods' Spicetec Flavors & Seasonings
business. Spicetec offers a range of flavours, spices and
savoury seasoning solutions to customers, primarily in North
America and operates from locations in Omaha, Nebraska;
Carol Stream, Illinois and Cranbury, New Jersey, employing
280 people. The transaction is expected to add approximately
USD 185 million to Givaudans revenue on a full year
basis. The total purchase price is USD 340 million, which
Givaudan plans to fund from existing resources. As the
planned transaction is structured as an asset deal, the
amounts paid include tax benefits which are typical with
this type of transaction. Final cash consideration will be
subject to adjustments for working capital. The planned
acquisition remains subject to formal approvals from the
relevant antitrust authorities. The transaction is expected
to close in the next 60-90 days.

Takasago
Full Year 2015-2016 Sales - May
13, 2016 - Takasago sales increased 7.6% to ¥ 141,660
million from ¥ 131,653 in the prior year ending March
31. Net income increased 91.4% to ¥ 4,880 million from
¥ 2,549 million.

Symrise
1st Qtr 2016 Sales - Holzminden,
Germany - May 10, 2016 - Symrise 1st Qtr 2015 group sales
increased 9.6% in euros (and 14% in local currencies) to
€731.8 million from €668.0 million in the first 3 months of 2015.
Scent & Care sales increased 21.7% to €344.3 million (or 22% in local currencies)
from €282.8 million in 2015. Flavor
& Nutrition sales increased 0.6% to €387.5 million (or 6% in local currencies)
from €385.3 million in
2015.

IFF
1st Qtr 2016 Sales- New York - May 9, 2016 - IFF 1st
Qtr sales increased $8.4 million, or 1.1%, to $783.3 million
from $774.9 million in the prior year quarter. 1st Qtr net
income declined 7.5% to $118.6 million. 1st Qtr flavor sales
declined 1.2% to $372.5 million while fragrance sales
increased 3.3% to $410.8 million. Currency neutral Flavor
sales grew 4%, including approximately 4 percentage points
related to the acquisition by IFF of Ottens Flavors. Flavors
growth was led by high-single-digit increases in North
America and Latin America and low-single-digit growth in
Greater Asia. Currency neutral Fragrance sales improved 8%,
including approximately 4 percentage points related to the
acquisition by IFF of Lucas Meyer Cosmetics. For fragrances,
all regions delivered growth led by a double-digit increase
in North America and high-single digit growth in Latin
America.

Sensient
F&F 1st Qtr 2016 Sales-
Milwaukee, April 19, 2016 - The Flavors & Fragrances
Group reported first quarter revenue of $198.3 million, a
decrease of 3.7% from $206.0 million reported in last
years first quarter. Segment operating income was down
-9.7% to $27.5 million compared to $30.5 million in the
first quarter of 2015. It should be noted that these figures
include items not normally considered Flavors &
Fragrances - mainly natural ingredients such as dehydrated
vegetables.

Givaudan
1st Qtr 2016 Sales- Geneva, 12 April 2016 - In the
first three months of 2016, Givaudan recorded sales of CHF
1,152 million, an increase of 5.8% on a like-for-like basis,
and 5.6% in Swiss francs compared to the previous year. In
the first three months of 2016, Givaudan recorded sales of
CHF 1,152 million, an increase of 5.8% on a like-for-like
basis, and 5.6% in Swiss francs compared to the previous
year. Total sales of Fragrance compounds (Fine Fragrances
and Consumer Products combined) increased by 9.5% on a
like-for-like basis. In Swiss francs, sales of compounds
increased by 7.4% to CHF 483 million in 2016 from CHF 450
million in 2015. The Flavour Division reported sales of CHF
591 million, a growth of 3.5% on a like-for-like basis and
an increase of 3.4% in Swiss francs.

Jeanette
Andrews - Thresholds - Unlocking Illusions for the Five
Senses and Beyond-March 21, 2016 - Ms. Andrews indeed
has demonstrated the magical illusion of perfume. In a
recent Interactive Show at the Museum of Contemporary Art
Chicago using a combination of research in philosophy,
psychology, science and art, Jeanette Andrews drew in the
crowd with not only her personality, but kept them there
with her mind - astounding the audience by her illusions -
Especially when she brought an audience member to the stage
and created a scent from the lady's thoughts. What was
scarier, was that the audience could smell it, also. And she
assures me that "Scent" will continue to be an important
theme in her work.

Guide
to Data Science and
Sustainability -
the Analytics and Data Science
Institute in the Graduate College at Kennesaw State
University , houses one of the countrys first Ph.D.
programs in Analytics and Data Science with a focus on
sustainability.

Diversifying
Flavor & Fragrance
Growth-
April 25, 2017 - A Perfumer &
Flavorist article by Patrick Mewton, Managing Director,
Clotilde Limited and John Leffingwell, President,
Leffingwell & Associates - This jointly written article
addresses three prevalent industry themes. Firstly, we set
into context the nature of the current peak of mergers and
acquisitions (M&A) activity that analytically examine
its empirical trend and impact on expected value. Secondly,
we probe the differing strategic objectives of deal
protagonists and investigate its impact on both F&F
increasing market concentration and the
diversif­ication of corporate strategy away from its
traditional flavor and fragrance (F&F) pure product
heartland. Lastly, we consider the reasons why some owners
may be contemplating a partnership process at this time and
highlight the alternative array of strategic options
available, some of which may better meet stakeholders'
objectives and retain the culture and identity of a
business, rather than the alternative of merely being
gobbled-up and digested in a takeover.

Firmenich
- Geneva, Switzerland, April 5, 2017 - Firmenich is pleased
to announce the appointment of Jerry Vittoria, as Head of
Fine Fragrance worldwide, in replacement of Olivier de
Lisle, who is retiring effective immediately. Jerry
Vittoria, most recently President Fine Fragrance North
America has been working closely with Oliver de Lisle to
ensure a smooth transition of activities.

Olfaction
- A Review - Updated
October 13, 2016 - now
with active links to most of the original
literature

FEMA 4829 is
2-Pyrrolidone with a faint and amine-like odor which
finds use in a wide variety of products.

...................

FEMA 4832 is
2-(3-(benzyloxy)propyl)pyridine. This material is the
subject of Japanese patent application JP,2015-083656, April
15, 2015 (Registration No. JP,5805902,B) by Kazu Miyazawa,
Yasutaka Okubo and Kenji Haraguchi assigned to T.Hasegawa.
The aroma/taste is slightly herbal, green, it has a natural
sense of full aroma in the nutty area, also. It has a
somewhat bitter taste when incorporated in high
concentrations in foods and beverages. With vegetables, it
has a spice-like taste at low concentrations. It improves
the taste of food and drink and imparts sweet & salty
notes, adds naturalness and enhances richness, especially
for the taste of milk and dairy products. The taste
enhancing effect is 2 - 10 times stronger than that of the
ethyl analog.

It should be
noted that Valencene (ex citrus, e.g. orange) has been
assigned FEMA No. 4334.

FEMA 4839 is
a mixture of 3- and 4-butyl-2-thiophenecarboxyaldehyde.
At the time of this writing, we have no flavor
information on FEMA 4839.

......

FEMA 4867 is
(-)-Rotundone = ( (3S ,5R ,8S
)-3,8-Dimethyl-5-prop-1-en-2-yl-3,4,5,6,7,8-hexahydro-2H-
azulen-1-one). This material is an important odor active
constituent of Agarwood (Oud), white & black
peppercorns, patchouli oil, Cypriol oil (Cyperus scariosus)
as well as various wines that exhibit peppery spicy notes.
It also is reported as being important to oak aged spirits.
Robin Clery & coworkers have described the odor using
GC-O as "woody, peppery, agarwood like". In 2006, Roman
Kaiser also reported that rotundone, a compound
characterized by a very low recognition threshold value and
already long known as a constituent of patchouli oil, is
also very important to this part of the agarwood
scent.

.....

FEMA 4868 is
4-(4-Methyl-3-penten-1-yl)-2(5H )-furanone. At the time
of this writing, we have no flavor information on FEMA
4868.

.....

FEMA 4869 is
4-(l-Menthoxy)-2-butanone =
4-[[(1R,3R,4S)-p-Menthane-3-yl]oxy]-2-butanone
=
4-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)butan-2-one.
This is a known compound (Bernal, Pablo, and
Joaquín Tamariz. "Synthesis of novel
ß-functionalized a-oximinoketones via hetero-Michael
addition of alcohols and mercaptans to enones." Tetrahedron
letters 47, no. 17 (2006): 2905-2909) which we strongly
suspect has refreshing cooling properties (however we can
find no odor or flavor description at the time of the
writing.)

......

FEMA 4878 is
Cordyceps sinensis fermentation product. Cordyceps
sinensis, the Chinese caterpillar fungus or
Dongchong-xia-cao in Chinese. It is a special mushroom with
a fruiting body formed on caterpillars. C. sinensis is one
of the most famous and highly valued medicinal fungi in
China, and has also attracted worldwide attention in recent
years as a nutriceutical. C. sinensis has been used
traditionally in China mainly as a general tonic for a
number of health benefits, such as strengthening the lung
& kidney functions, restoring health after prolonged
sickness, enhancing the physical performance, and improving
the quality of life. Recent studies have shown several
pharma-cological activities of Cordyceps including
antitumor, antiaging, anti-fatigue, anti-inflammation,
anti-atherosclerosis and antioxidant activities. As the wild
or natural caterpillar fungi as fungus fruiting
body-caterpillar complexes are rare and cannot meet the
increasing demand, mycelial fermentation has become a major
source of Cordyceps materials. While the flavor properties
vary by method of fermentation, they are generally from a
mild soy protein note to not really pleasant. The
Identification value as reviewed by the FEMA Expert Panel =
Approximately 25% alpha-glucans; approximately 60-70%
maltodextrin and its degradation products with no more than
1.5% protein.

The
FEMA Flavor Ingredient
Library- September 23, 2015 - FEMA has
officially launched its online Flavor Ingredient Library,
a free and easily accessible resource for
researchers, the media and consumers seeking information on
substances that are generally recognized as safe (GRAS) for
use as flavor ingredients. All
the FEMA GRAS lists are available for
FREE.

China
Flavor Regulations-
On 24 December 2014, The National
Health and Family Planning Commission of the Peoples
Republic of China (NHFPC) announced that the China National
Standards for Food Additives (GB 2760-2014), which includes
the latest list of flavoring ingredients, would go into
effect on May 24, 2015. This regulation contains a more
complete (and updated) list of flavor ingredients than the
flavoring regulation GB
29938-2013,which defines the
purity standards for flavor chemicals, that took effect June
1, 2014.

Chemistry
and the Sense of Smell
- This book by Charles Sell provides
an account of the totality of fragrance chemistry in one
volume. It describes the chemistry of odorous materials, how
and why they are produced in nature, how they are produced
and used commercially, how they are analyzed and
characterized, the chemistry of how we perceive them, and
their role in our everyday lives. The final chapter reviews
the major intellectual challenges for fragrance chemists and
considers the future of the field.

...........

Scent
and Chemistry -
This book is the long awaited
completely revised and extended edition of Günther
Ohloff's standard work "Scent and Fragrances: The
Fascination of Odors and Their Chemical Perspectives". The
prominent chemists Günther Ohloff, Wilhelm Pickenhagen,
and Philip Kraft convey the scientist, the perfumer, as well
as the interested layman with a vivid and up-to-date picture
of the state of the art of the chemistry of odorants and the
research in odor perception. The book details on the
molecular basis of olfaction, olfactory characterization of
perfumery materials, structure-odor relationships, the
chemical synthesis of odorants, and the chemistry of
essential oils and odorants from the animal kingdom, backed
up by ca. 400 perfumery examples and historical
aspects.

...........

The
Chemistry and Biology of
Volatiles(August
2010) -
A Fascinating book edited by Andreas
Herrmann of Firmenich. Volatile compounds are molecules with
a relatively low molecular weight allowing for an efficient
evaporation into the air. They are found in many areas of
our everyday-life: they are responsible for the
communication between species such as plants, insects or
mammals; they serve as flavours or fragrances in many food
products or perfumed consumer articles.

...........

Natural
Products in the Chemical Industry
(February 2015). Natural Products in the Chemical Industry
(2d Ed.) by Bernd Schaefer of BASF is not a conventional
textbook, but rather an invitation to join an entertaining
journey that takes you into the fascinating world of natural
products. This book features diverse compound classes from a
number of areas including fragrances and flavourings. The
sections on Ambrox, menthol, ionone and the rose ketones (to
mention a few) are fascinating chemistry.

EFSA Opinions- Reviews the latest
opinions of the Scientific Panel on food additives,
flavourings, processing aids and materials in contact
with food [AFC] as relates to the EC Register
list of flavourings.

Evolva
gains exclusive license to develop and commercialise
nootkatone globally for pest
control - 5 April 2016 
Evolva (SIX: EVE) announces that it has just signed a
license agreement with the US Centers for Disease Control
and Prevention (CDC) that grants Evolva the exclusive
worldwide patent rights to develop and commercialise
nootkatone for the control of a wide range of disease and
virus vectors such as ticks, mosquitoes, fleas, flies, lice,
bed bugs, and other biting insects. Evolva announced just
recently that it is expanding its nootkatone research focus
to include the mosquitoes that transmit Zika and other
viruses. This expanded focus is included in the
comprehensive Cooperative Research and Development Agreement
(CRADA) now in place between Evolva and the CDC. The World
Health Organisation (WHO) recently declared Zika virus a
global public health emergency. Nootkatone could play an
important role in the global response to the spread of Zika.
CDC research has shown nootkatone both repels and kills the
yellow fever mosquito, Aedes aegypti, and the black-legged
tick, Ixodes scapularis which transmits Lyme disease.
Nootkatone appears to have a mode of action distinct from
that of currently used pesticides and therefore could
potentially be valuable for mitigating pesticide resistance
in mosquito vectors. Nootkatone already occurs in the
natural environment and has an established track record as a
flavor and fragrance ingredient, providing attractive
characteristics in a number of respects. Nootkatone can be
extracted in minute quantities from the skin of grapefruit
or the bark of the Alaska yellow cedar (also known as the
Nootka cypress), or produced on an industrial scale from
brewing via yeast fermentation. Evolva is currently
performing all necessary safety and efficacy studies to get
nootkatone approved by the US Environmental Protection
Agency, initially as a repellent against the blacklegged
tick. We now have the tools in place to accelerate the
research and commercial development of nootkatone as a
next-generation pest control compound against a broad range
of biting insects, including the mosquitoes that transmit
Zika, chikungunya, dengue, and West Nile viruses, said
Evolva CEO Neil Goldsmith.

Frutarom
Full Year 2015 Sales- Haifa, Israel  March 17, 2016
- Frutarom's sales in 2015 as reported in US dollars grew
6.5% to reach a record US$ 872.8 million, reflecting
constant-currency growth over the previous year of 4.9% on a
pro-forma basis. Sales for the Flavors activity in 2015 as
reported in US dollars rose 3.0% to reach a record US$ 607.5
million compared with US$ 589.8 million the previous year,
reflecting constant-currency growth on a pro-forma basis of
5.3% from the parallel period. Currency effects reduced
sales on a pro-forma basis by 14.3%. Sales for the Specialty
Fine Ingredients activity in 2015 as reported in US dollars
rose 16.8% to reach US$ 184.9 million compared with US$
158.4 million the previous year, reflecting
constant-currency growth on a pro-forma basis of 1.5% from
the parallel period. Currency effects reduced sales on a
pro-forma basis by 6.0%. Reported net income for 2015 rose
9.7% and reached a record US$ 96.1 million.

Symrise
Full Year 2015 Sales - March 8,
2016 - Symrise 2015 sales increased to € 2,601.7 million
(2014: € 2,120.1 million). This represents growth of 23 % in
reporting currency and 18 % at local currency. The Diana
Group, which was acquired in mid-2014 and is now fully
integrated, contributed sales of € 524.8 million (2014: €
233.9 million). Excluding the contribution of Diana, Symrise
also generated strong sales growth with 10 % in reporting
currency and 6 % at local currency. Symrise increased its
net income in the year under review by 17 % to € 246.8
million (2014 normalized: € 211.6 million). The Scent &
Care segment achieved sales of € 1,073.7 million in 2015
(2014: € 980.4 million). This represents an increase of 10 %
(4 % at local currency). All business divisions contributed
to growth, in particular Aroma Molecules and Cosmetic
Ingredients. Symrise benefited above all from strong demand
for menthol and cosmetic active ingredients. Flavor &
Nutrition experienced a substantial 34 % increase in sales
(31 % at local currency) and benefited in particular from
strong demand for beverages and savory applications.
However, in the Symrise 2016 annual report the Nutrition
sales of 547.8 million euros were separated out from the
Flavor sales. Flavor sales were therefor 980.2 million euros
resulting in the the total F&F sales of the company
being 2,053.9 million euros. The Diana Group also achieved
strong growth, especially with pet food and aquaculture
applications. Excluding Diana, sales increased by 11 % (8 %
at local currency). In January 2016 Symrise expanded its
fragrance activities with the acquisition of US-based
Pinova
Holdings, Inc. (including Renessenz).
This has given the company access to additional natural
ingredients which are used in perfume compositions.
Moreover, Symrise has expanded its forward integration in
menthol to include cooling substances for oral
care.

Robertet
Full Year 2015 Sales - March 7,
2016 - Robertet has reported that its net consolidated sales
in 2015 totaled EUR 435 million, up 11.6% compared to 2014.
At constant rates and structure, turnover was up 7.5%.
Turnover achieved was 85% abroad and all geographies are
growing. Europe posted strong growth thanks to the good
performance of the Commodities Division and Latin America
thanks to the recovery of Brazil. The unaudited consolidated
net profit should be around 36 million euros, an increase of
22%, higher than expected. Final results will be published
no later than 30 April 2016.

IFF
Full Year 2015 Sales- February 10, 2016 - IFF's net sales
for 2015 were $3,023.2 million, a decline of 2.1%. Adjusted
Currency Neutral Sales increased 5%. Net income for the year
declined 0.7% to $411.7 million. 4th Qtr sales declined 5.3%
to $715.6 million. Full year Flavor sales declined 1% to
$1,443 million. Full year Fragrance sales declined 3.1% to
$1,580.2 million.

T.
Hasegawa 1st Qtr 2015-2016 Sales
Results - February 5, 2016 -
Sales for the 1st Qtr 2015-2016 period ending Dec. 31, 2015
were up 7.5% to ¥ 11,209 million compared to ¥
10,430 million in the prior year. Net income for the period
increased 29.2% to ¥ 713 million.

Sensient
F&F Full Year 2015 Sales-
Milwaukee, Feb. 04, 2016 - The Flavors & Fragrances
Group reported revenue of $819.0 million for the year ended
December 31, 2015, a decrease of 3.8% from $851.5 million
reported in 2014. Operating income increased approximately
1%, to $121.9 million in 2015, from $120.9 million in 2014.
The Flavors & Fragrances Group reported fourth quarter
revenue of $201.0 million, a decrease of 1% from $203.1
million reported in last years fourth quarter.
Operating income increased 6.3% to $27.5 million compared to
$25.9 million in the fourth quarter of 2014. The above
figures includes items not normally considered Flavors &
Fragrances - mainly natural ingredients such as dehydrated
vegetables. Excluding these items, sales of traditional
Flavors & Fragrances in 2015 were $667.9 million vs
$715.8 million in 2014 as restated (-6.7%).

Givaudan
Full Year 2015 Sales- Geneva, 2 February 2016 - Givaudan
Group full year sales were CHF 4,396 million, an increase of
2.7% on a like-for-like basis and a decline of 0.2% in Swiss
francs when compared to 2014. Fragrance Division sales were
CHF 2,096 million, an increase of 1.9% on a like-for-like
basis and a decline of 0.6% in Swiss francs. Flavour
Division sales were CHF 2,300 million, an increase of 3.5%
on a like-for-like basis and 0.2% in Swiss francs. Net
income increased to CHF 635 million in 2015 from CHF 563
million in 2014, an increase of 12.7%. This results in a net
profit margin of 14.4%, versus 12.8% in 2014.

Huaboa
Intl. Half Year 2015-2016 Sales -
November 27, 2015 - Huaboa International net sales for the
half year ending September 30, 2015 were 1,693.0 million
Hong Kong dollars (-21.3%) of which 82.3% was from the
flavors & fragrance related segments. The F&F
segments sales decrease was -14.3% to 1,394.2 million
HKD.

Frutarom
9 Month 2015 Sales- Haifa, Israel  November 19,
2015 - Frutarom Industries Ltd. reports, attaining in the
first nine months of 2015, record levels in sales reaching
US$ 647.2 million (+4.8%), and in net income reaching US$
72.6 million. Frutarom's sales in the third quarter of 2015
rose by 11.3% to reach a quarterly record of US$ 234.5
million compared with US$ 210.8 million in the parallel
quarter, reflecting constant-currency growth on a pro-forma
basis4 of 4.5% from the parallel period.

Takasago
Half Year 2015-2016 Sales -
November 11, 2015 - Takasago half year sales for the period
ending September 30, 2015 were ¥ 72,123 million, an
increase of 8.8% over the prior year period. Operating
income increased 67.1% to ¥ 4,529 million. Net income
increased to ¥ 4,057 million (+202%)

Symrise
9 Month 2015 Sales 
November 11, 2015 - For the first nine months of 2015,
Symrise outperformed the overall market and significantly
boosted its earnings. The Group benefited from strong demand
in both business segments and in all regions. Symrise
increased its sales by 29% to €1,977.0 million (9M 2014:
€1,530.0 million) and its earnings before interest, taxes,
depreciation and amortization (EBITDA) by 30% to €448.5
million (9M 2014 normalized: €343.8 million). Sales in the
Scent & Care segment rose by 10% to €812.3 million (9M
2014: €736.8 million). The Flavor & Nutrition segment
increased sales by 47% to €1,164.7 million (9M 2014: €793.2
million) in the first nine months of the year. At local
currency, this amounts to a 41% gain. Even without the Diana
Group, the segment achieved strong organic growth and
increased sales by 13% (9% in local currency).

T.
Hasegawa Full Year 2014-2015 Sales
Results - November 11, 2015 - for
the 12 months ending September 30, 2015, T. Hasegawa's
consolidated net sales were up 5.1% to ¥ 47,228 million
compared to ¥ 44,917 in the prior year. Net income for
the period declined 6.0% to ¥ 3,043 million.

Firmenich
supports world-class research as it celebrates its 120th
anniversary- Geneva, Switzerland, November 2nd
2015  Marking its 120th Anniversary, Firmenich proudly
announces the creation of two Next Generation
Firmenich programs to advance basic Research in the areas of
Neurosciences and Sustainability. Firmenich established
these endowed initiatives at leading universities in its two
chosen fields, Stanford University in the United States and
the Ecole Polytechnique Fédérale de Lausanne
(EPFL) in Switzerland.

Givaudan
9 Month 2015 Sales- Geneva, 9 October 2015 - In the
first nine months of 2015 Givaudan recorded sales of CHF
3,296 million, an increase of 2.0% on a like-for-like basis
and a decline of 0.5% in Swiss francs compared to the
previous year. Including Soliance and the recently acquired
company Induchem, the growth was 1.8% in local currencies.
Induchem contributed CHF 2 million following the acquisition
on 31 August 2015. 3rd Qtr Group sales were CHF 1,112
million (-0.9%) and +3.3% on a like-for-like basis.
Fragrance Division sales were CHF 1,563 million for the
first nine months of 2015, an increase of 0.7% on a
like-for-like basis and a decline of 1.5% in Swiss francs.
3rd Qtr Fragrance sales were CHF 540 million (-2.2%) and
+2.0% on a like-for-like basis. Flavour Division sales were
CHF 1,733 million during the first nine months of 2015, an
increase of 3.3% on a like-for-like basis and +0.4% in Swiss
francs. 3rd Qtr Flavour sales were CHF 572 million (+0.4%)
and +4.6% on a like-for-like basis.

Firmenich
2014-2015 Sales- Oct. 7, 2015 - For the financial
year ended June 30, 2015, Firmenich posted sales of ~CHF
3,008 million, an increase of 1.9% in Swiss francs and 3% in
local currencies. For the first time this year, Firmenich
issued an integrated report, sharing both its Business and
Sustainability Performance, as they go hand in hand, at the
core of the Groups vision and strategy.

Frutarom
1st Qtr 2015 Sales- Haifa, Israel  May 20, 2015 -
Frutarom sales in the 1st Qtr were US$ 194.2 million
(+3.0%). 1st Qtr 2015 net profit rose by 17.1% to reach US$
21.4 million, compared to US$ 18.3 million in the 1st Qtr
2014. Frutarom sales from Flavors activity in Q1 2015 as
reported in US dollar terms totaled US$ 133.4 million as
opposed to US$ 134.2 million in Q1 2014. Frutarom sales from
Specialty Fine Ingredients activity in Q1 2015 as reported
in US dollar terms rose 5.5% to reach US$ 43.2 million as
opposed to US$ 41.0 million in Q1 2014.

A
doctoral defense delayed by injustice - for 77
years - Weve heard of
people taking a long time to get their Ph.D.s, but Ingeborg
Syllm-Rapoport surely holds the record. More than 8 decades
elapsed between the time she entered graduate school
studying diphtheria at the University of Hamburg in Germany
and her successful thesis
defense.

Takasago
Full Year 2014-2015 Sales - May
14, 2015 - Takasago sales increased 0.5% to ¥ 131,653
million from ¥ 131,036 in the prior year ending March
31. Net income decreased 15.7% to ¥ 2,549 million from
¥ 3,025 milllion.

IFF
1st Qtr 2015 Sales- New York - May 12, 2015 - IFF 1st
Qtr sales increased $4.7 million, or 0.6%, to $774.9 million
from $770.2 million in the prior year quarter. Currency
neutral sales (formerly referred to as local currency sales)
increased 6% reflecting broad-based growth in both
businesses and across all regions. Sales to the emerging
markets, which now represent 51% of total company sales,
grew 9% on a currency neutral basis. 1st Qtr 2015 Flavor
sales were $377.1 million (+2.9%). Currency neutral Flavor
sales grew 9% in the first quarter with growth across all
regions led by double-digit growth in Latin America and
North America and high single-digit growth in EAME.
Fragrance sales were $397.8 million (-1.5%). Currency
neutral Fragrance sales growth was +5%. IFF's 1st Qtr net
income was $128.3 million, +20.2% from 2014.

T.
Hasegawa Half Year 2014-2015 Sales
Results - May 11, 2015 - for the
1st 6 months ending March 31, 2015, T. Hasegawa reported
sales of ¥ 21,879 million compared to ¥ 21,696
million in the prior year period, an increase of 0.8%. Half
year net income declined 25.2% to ¥ 1,573
million.

Vibration
Theory of Olfaction Takes a Hit -
May 8, 2015 - An international team of scientists led by
University at Albany Distinguished Professor of Chemistry
Eric Block, have demonstrated that the vibrational theory of
olfaction, one of the two major theories explaining how the
sense of smell functions, is not plausible. In a paper
entitled "Implausibility of the vibrational theory of
olfaction" (Proc. Natl. Acad. Sci. USA 2015, DOI:
10.1073/pnas.1503054112),
Block and co-authors found that the human musk-recognizing
receptor, OR5AN1, identified using a heterologous OR
expression system and robustly responding to
cyclopentadecanone (Exaltone®) and muscone, fails to
distinguish isotopomers of these compounds in vitro.
Furthermore, the mouse (methylthio)methanethiol-recognizing
receptor, MOR244-3, as well as other selected human and
mouse ORs, responded similarly to normal, deuterated, and
13C isotopomers of their respective ligands,
paralleling results with the musk receptor OR5AN1. These
findings suggest that Luca Turin's proposed vibration theory
does not apply to the human musk receptor OR5AN1, mouse
thiol receptor MOR244-3, or other ORs examined. Also,
contrary to the vibration theory predictions,
muscone-d30 lacks the 1,380- to
1,550-cm-1 IR bands claimed to be essential for
musk odor. Furthermore, theoretical analysis shows that the
proposed electron transfer mechanism of the vibrational
frequencies of odorants could be easily suppressed by
quantum effects of nonodorant molecular vibrational modes.
These and other concerns about electron transfer at ORs,
together with extensive experimental data, argue against the
plausibility of the vibration theory. In the May 4th issue
of C&EN News
Turin responded "...that Block and colleagues did their
experiments with cells in a dish rather than within whole
organisms. ... and that expressing an olfactory receptor in
human embryonic kidney cells doesnt adequately
reconstitute the complex nature of olfaction and is not
biologically significant". Block and colleagues responded at
http://www.pnas.org/content/112/25/E3155.full

Symrise
1st Qtr 2015 Sales - Holzminden,
Germany - May 5, 2015 - Symrise 1st Qtr 2015 group sales
increased 42.2% in euros (and 33% in local currencies) to
€668 million from €469.6 million in the first 3 months of 2014.
Net income for the period increased 31 % to € 68.0 million
vs € 51.9 in 2014. Flavor & Nutrition posted a sales
growth of 79.2 % (70 % at local currency) in the first
quarter, with sales totaling € 385.3 million (Qtr1 2014 = €
215.0 million). Scent & Care 1st Qtr sales increased by
11.1 % to € 282.8 million (3% in local currencies) vs. 2014
sales of € 254.6 million. Dr. Heinz-Jürgen Bertram, CEO
of Symrise AG, said: We had an excellent start into
the year. The strong growth across all segments and regions
shows that we are ideally positioned with our clear strategy
and unique set-up. Diana has more than fulfilled our
expectations following its integration. But Symrise also
achieved new records in terms of growth and profitability
with its existing customer base. Despite uncertainties in
individual markets, we remain confident for the coming
quarters.

IFF
Completes Acquisition of Ottens
Flavors-
New York, May 1, 2015 - International Flavors &
Fragrances Inc. (NYSE:IFF), a leading global creator of
flavors and fragrances for consumer products, today
announced that it has successfully completed the previously
announced acquisition of Henry H. Ottens Manufacturing Co.,
Inc. Financial terms of the transaction were not
disclosed.

Sensient
F&F 1st Qtr 2015 Sales-
Milwaukee, April 20, 2015 - The Flavors & Fragrances
Group reported first quarter revenue of $206.0 million
compared to the $214.3 million reported in last years
first quarter (-3.9%). Operating income increased 0.7% to
$30.5 million, compared to $30.2 million in the first
quarter of 2014. Beginning in the first quarter of 2015, the
results of operations for the Companys businesses in
Central and South America, previously reported in the
Corporate & Other segment, are now reported in the
Flavors & Fragrances segment. Results for 2014 have been
restated to reflect these changes. The 2015 and 2014
restructuring and other costs related to continuing
operations are reported in the Corporate & Other
segment.

IFF
to Acquire Ottens Flavors to Strengthen North American
Business-
New York, April 13, 2015 - International Flavors &
Fragrances Inc. announced that it has entered into an
agreement to acquire Henry H. Ottens Manufacturing Co., Inc.
This acquisition is an exciting one as its the
first step in our redefined strategy to win where we
compete, said IFF Chairman and CEO Andreas Fibig".
"Once completed, the deal will strengthen our operations in
North America and enhance our ability to meet the needs of
our customers through a differentiated service model geared
towards enhancing collaboration and building greater
customer intimacy. Were looking forward to welcoming
Ottens Flavors employees into the IFF family.
The transaction, which will be funded from existing
resources, is expected to add approximately $60 million in
revenue on an annualized basis and be slightly accretive to
IFFs earnings per share in 2015, excluding transaction
costs. Financial terms of the deal have not been
disclosed.

Givaudan
1st Qtr 2015 Sales- Geneva, 10 Apr 2015 - In the first
three months of 2015, Givaudan recorded sales of CHF 1,091
million, an increase of 0.9% on a like-for-like basis, and
0.4% in Swiss francs compared to the previous year. The
Fragrance Division recorded sales of CHF 519 million, a
growth of 0.3% on a like-for-like basis and an increase of
0.7% in Swiss francs. Including Soliance, the growth was
2.0% in local currencies. The sales of Soliance, which was
acquired on 2 June 2014, amounted to CHF 8 million for the
first three months of 2015, a double-digit growth when
compared to the same period of last year. The Flavour
Division reported sales of CHF 572 million, a growth of 1.5%
on a like-for-like basis and a slight increase of 0.1% in
Swiss francs.

Firmenich
Appoints New Chief Research
Officer- Geneva, Switzerland, March 24, 2015
 Firmenich appoints Professor Geneviève Berger
as Chief Research Officer, effective July 1st 2015. She will
report directly into the Group CEO, Gilbert Ghostine, as a
member of his executive team, after most recently serving as
Chief Research and Development Officer at Unilever.
Professor Berger will be based in Geneva, Switzerland and
succeed to Dr. Toni Gautier, who is retiring from the Group
at the end of June.

Frutarom
Full Year 2014 Sales- Haifa, Israel  March 16, 2015
- Frutarom sales for the full year 2014 increased 21.6% to
U.S. $819.5 million. Net income for the year increased 37.7%
to $87.6 million. Flavors and Specialty Fine Ingredients
sales grew to $741.0 million (+16.9%).

T.
Hasegawa 1st Qtr 2014-2015 Sales
Results - for the 3 months ending
December 31, 2014 T. Hasegawa's consolidated net sales were
down -3.5% to ¥ 10,430 million compared to ¥
10,806 in the prior year. Net income for the period declined
34.8% to ¥ 552 million.

Symrise
Full Year 2014 Sales -
Holzminden, Germany - March 10, 2015 - In the fiscal year
2014, Symrise AG exceeded its targets and substantially
expanded its market position. Group sales increased 15.8% to
€ 2120.1 million from € 1830.4 million in 2013. In local
currencies, sales increased 18.3%. 4th Qtr performance was
particularly strong, with an increase in Group sales to €
590.1 million vs. 2013 at € 429.2 million (+37.5%). Net
income normalized for one-time effects was up 23 % to €
211.6 million. Full year Scent & Care sales were € 980.4
million vs. € 960.4 million in 2013 (+2.1%). Full year
Flavor & Nutrition sales increased 31% to € 1139.7
million vs. € 869.9 million in 2013. This includes € 233.9
million contributed from the Diana Group acquisition since
July 2014.

Takasago
9 Month 2014-2015 Sales- February 12, 2015 - Takasago's 9
Month sales for the period ending December 31 were ¥
99,085 million (-0.3%). Net income for the 9 month period
declined 3.6 % to ¥ 3,256 million.

IFF
Full Year 2014 Sales- New York - February 12, 2015 -
Reported net sales for the 2014 full year were $3,088.5
million, up +4.6% from 2013. For the full year, Flavor sales
were up +2.4% to $1,457.1 million, while Fragrance sales
increased to $1,631.5 million (+6.6%). In the 4th Qtr., IFF
net sales increased +4.3% to $756.1 million vs 2013. 4th
Qtr. Flavor sales were $356.3 million (+3.9%) while
Fragrance sales were $399.8 million (+4.6%). IFF's 2014 net
income was $414.5 million, +17.3% from 2013.

Sensient
F&F Full Year 2014 Sales-
Milwaukee, Feb. 5, 2015 - Sensient's Flavors &
Fragrances Group reported full year revenue of $847.0
million and $876.5 million in 2014 and 2013, respectively
(-3.4%). Operating income was $119.1 million for the year
compared to $120.3 million last year. Foreign currency
translation reduced both revenue and operating income by
approximately one percent in 2014. In local currency,
revenue was off about 1%, and operating income was
comparable to 2013. 4th quarter revenue was $201.9 million
compared to the $209.0 million in 2013 (-3.4%).

Mane
- Full Year 2014 Sales increase -
February 4, 2015 - Mane achieved sales of €
769 million in 2014, up 6.4% from
€ 723 million in 2013. Using the 2014
yearly average EUR/USD Forex exchange rate, 2014 sales in
USD were $ 1,022 million (personal communication).

Carl Djerassi (1923-2015)

Dr.
Carl Djerassi, renowned scientist,
author, and philanthropist, died peacefully, surrounded by
family and loved ones, in his home in San Francisco,
California on Friday, January 30, 2015. He was 91. His life
and career included remarkable productivity and achievement
in science, academia, and the arts, as well as personal
tragedy in his expulsion from his childhood home following
the Nazi Anschluss in 1938. Best known as one of the
inventors who patented the key ingredient that led to the
development of the first oral contraceptive in 1951. He was
also instrumental in creating the first commercial
antihistamines in the 1940s. He was the author of more than
1,200 scientific articles.Throughout the 1960s and 1970s,
Djerassi continued to do significant scientific work, as a
professor in the Department of Chemistry at Stanford
University, and as an entrepreneur. He pioneered novel
physical research techniques for mass spectrometry and
optical rotatory dispersion and applied them to the areas of
organic chemistry and the life sciences.

Givaudan
Full Year 2014 Sales- Geneva, 29 January 2015  For
the full year 2014 Givaudan recorded sales of CHF 4,404
million, an increase of 3.7% on a like-for-like basis and
0.8% in Swiss francs when compared to 2013. Net income was
CHF 563 million, up 14.9% year on year. Developing markets
grew 7.0%, and mature markets grew 1.1%, both on a
like-for-like basis. Fragrance Division sales were CHF 2,108
million, an increase of 3.6% on a like-for-like basis and
1.2% in Swiss francs. Flavour Division sales were CHF 2,296
million, an increase of 3.7% on a like-for-like basis and
0.4% in Swiss francs.

In
Memoriam of E. Demp Alford
- January 8, 2015 - On January 7th,
2015 Demp Alford passed away at the age of 74 in Louisville
KY. A career mass spectroscopist and President of Alford
Consulting for the last 20 years, he was well known to those
in the flavor & fragrance industry for his unique
ability to unravel the most difficult GC-MS analyses. His
consulting clients included many well-known companies in the
USA, Japan, India and Europe. He was often sought after to
assist companies in improving their own GC-MS laboratory
techniques.

His generosity
in assisting others is exemplified by a note I received from
someone he assisted in setting up to be a competitor. "My
[GC-MS] consulting business is doing really good and
I am so grateful for the opportunity Demp gave me. I think
he believed in me before I believed in
myself...".

He was an avid
gardener, feeding many friends, neighbors and people in need
every year. He was known for his strong work ethic, sharp
mind and a wonderful sense of humor. He is survived by his
wife Donna, his daughter Nikola and three
brothers.

Perilla
aldehyde (p-Mentha-1,8-dien-7-al) is deleted as an approved
flavorant by the EU- October 1, 2015 - On July 23, 2015
EFSA reported that the flavouring substance
p-Mentha-1,8-dien-7-al (Perilla aldehyde) has been shown to
be genotoxic (damaging to DNA) in a new study on animals,
evaluated by EFSAs experts. On October 1, 2015 - in
COMMISSION REGULATION (EU) 2015/1760 -
p-Mentha-1,8-dien-7-al was removed from the list of approved
flavorants.

Eugene
S. Buday - September 28, 2015 - Gene
Buday, founder of GSB
& Associates, Flavor Creators
in Kennesaw, Georgia has passed away at age 82. His career,
which began in the 1950s, included roles with Felton,
Polaks Frutal Works (PFW), Hercules, Synfleur, Fries
and Fries, Aromatics International and AFF. Buday
established GSB & Associates, Inc, in 1984. He was a
certified flavor chemist and past president of the Society
of Flavor Chemists. Buday remained active in the industry
until his passing. Mr. Buday is survived by his wife, Anne
Buday, son, Steven Buday, daughter, Corinne Baskin, and his
son in law, Michael Baskin. Buday's services will be
private. The family asks that any contributions be sent to
Wellstar Community Hospice at Kennesaw Mountain, 200 South
Park Place, Suite 202, Atlanta, GA 30339.

Symrise
to Acquire Pinova Holdings 
September 21, 2015 - Symrise is acquiring Pinova Holdings
for US$ 397 million. Subject to conditions to be met within
12 months, the seller will receive a premium of US$ 20
million. Dr. Heinz-Jürgen Bertram, CEO of Symrise AG,
said: "With the acquisition of Pinova Holdings, which owns
the operating companies Pinova and Renessenz, we are taking
a big step in the growth of our Aroma Molecules business. In
view of the increasing importance of natural and renewable
raw materials for the fragrance industry, the product range
ideally complements our current portfolio. Pinova Holdings
has recognized expertise and is very well positioned in that
area. In addition, Pinova Holdings will broaden our
portfolio of ingredients in Oral Care as well as some
attractive new market segments. At the same time, the
company will benefit from our global presence and sales
structure as well as our R&D expertise." The product
portfolio of Pinova Holdings comprises numerous specialized
products in three business segments. In the Fragrance
Ingredients segment the company is a leading supplier of
fragrances derived from natural and renewable raw materials,
including products based on wood, orange oils and paper
production by-products. Pinova Holdings will thus complement
the existing portfolio of Symrise. As a result, the Group
will have access to major and high-volume platforms for
fragrance ingredients. In the Sensory Ingredients segment,
Pinova Holdings main focus is on cooling substances used in
combination with menthol-based products to enhance the
cooling effect. They are used in the manufacturing of oral
care products, chewing gum and beverages, among other areas.
Symrise is one of the global leaders in the production of
synthetic L-menthol, and with this acquisition is
substantially strengthening its competitiveness in this
particular field. Pinova Holdings has close customer
relationships with leading global companies in the consumer
goods industry, including  similar to Symrise 
many long-term strategic partnerships. The company has
manufacturing operations at three locations: Brunswick and
Colonels Island, Georgia, USA, and in Jacksonville,
Florida, USA. In the fiscal year 2014, Pinova Holdings
recorded sales of US$ 287 million with a workforce of about
400 employees. In the same period, the adjusted EBITDA
amounted to US$ 37.4 million. Subject to regulatory
approval, the deal is expected to close at the beginning of
2016. Symrise plans to move forward quickly with the
integration of Pinova Holdings, expecting to achieve
annually synergy effects worth € 20 million by
2020.